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Pelvic floor reconstruction is usually accompanied with the implantation of a surgical 
mesh, which frequently results in a foreign body response with associated 
complications. An ideal surgical mesh that allows force generation of muscle tissues 
without significant granulation tissue and/or fibrosis is of significant clinical interest. In 
this dissertation, the in vitro and in vivo responses of a chitosan coating on high 
molecular weight polypropylene mesh (Ch-PPM) in comparison with commercially 
available meshes were explored.  
 
In the first study, we found that application of a 0.5% (w/v) Ch-PPM elicited 
preferential attachment of myoblasts over fibroblast attachment in vitro. Therefore, we 
tested the hypothesis that 0.5% Ch-PPM will encourage skeletal muscle tissue ingrowth 
and decrease fibrosis formation in vivo. In the second topic of investigation, we 
implanted 0.5% Ch-PPM, collagen-coated polypropylene mesh (PelvitexTM; C.R. Bard), 
and polypropylene (Avaulta Solo®; C.R. Bard) alone using a rat abdominal defect 
model. Force generation capacity and inflammatory response of each mesh were 
 evaluated 2, 4, and 12 weeks post-implantation. We found that chitosan coating is 
associated with the restoration of functional skeletal muscle with histomorphologic 
characteristics that resemble native muscle and an early macrophage phenotypic 
response that has previously been shown to lead to more functional outcomes. Finally, 
we tested the mesh types in the same in vivo rat abdominal defect model to: 1) establish 
a relationship between the ratio of collagen types I/III and mechanical strength, and 2) 
determine the collagen deposition and mechanical strength of a chitosan-coated 
polypropylene mesh. By characterizing the inflammatory response, muscle contractility, 
and structural properties of mesh types after introduction in a small animal model, we 
hope to provide more insight for clinicians to reach a more educated decision for 
selection of a particular material for pelvic floor repair. 
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Chapter 1 
 
Introduction 
Nearly half of the parous women in the U.S. have suffered from some degree of 
genital prolapse (1,2). Each year, an estimated 135,000 women undergo surgery for 
urinary incontinence and 225,000 women undergo surgery for pelvic organ prolapse in 
the United States (3). One in nine American women requires a primary operation for a 
pelvic floor disorder (PFDs), and almost a third of those women suffer from recurrent 
prolapse, which requires a second operation.  These surgeries and treatment options 
had a direct cost of over $1 billion in 1997 in the United States (4).  It is expected that 
urogynecological care will escalate 45% between the years 2000 and 2030 (5). 
In this thesis, the effects of chitosan coating on polypropylene mesh samples for 
pelvic floor reconstruction are investigated. The effective management of PFD and 
providing proper treatment to women with PFDs requires knowledge of the anatomy 
and function of the female pelvic floor and its supporting structures. 
 
1.1 Pelvic Cavity Anatomy 
The pelvic cavity is defined as the space bounded by the bones of the pelvis and 
containing the pelvic viscera.  The pelvic cavity is made up of the bony structure, 
endopelvic fascia, and pelvic floor. 
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1.1.1 Bony Scaffolding and Endopelvic Fascia 
The bones that make up the pelvis provide the framework on which the soft 
tissue supports (muscles, ligaments, and fascia) are attached. The bony pelvis consists of 
the two hipbones that are fused to the sacrum posteriorly and to each other anteriorly at 
the pubic symphysis. Each hipbone is composed of the ilium, ischium, and pubis, which 
are connected by cartilage in young children but fuse together for adults (6). 
 Endopelvic fascia is a network of fibromuscular tissue positioned between the 
peritoneum and the levator muscles. It surrounds and connects the bladder, uterus, 
vagina, and rectum to the pelvic walls, so to stabilize the pelvic viscera (7). 
 
1.1.2 Muscular Supports 
The pelvic floor is a group of muscles that form a sling or hammock across the 
opening of a pelvis. These muscles, with surrounding tissues, keep the pelvic organs in 
place so they can function correctly. The pelvic floor, a three-dimensional structure, 
works as a unit, and although the muscles are often referred to independently, the 
boundaries are often difficult to delineate and they perform analogous physiologic 
functions (7).  
The muscles that make up the pelvic floor consist of both type I and type II fibers 
(7). Type I muscle fibers are slow twitch and provide sustained muscle tone of the 
pelvic floor. These fibers play a critical role in delivering dynamic pelvic floor support, 
consequently taking the mechanical stress away from the endopelvic connective tissue 
attachments. Type II fibers are fast twitch fibers that are responsible for the reflex 
contractions of the pelvic floor associated with sudden increases in intra-abdominal 
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pressure (i.e. coughing, childbirth). There are three regions that make up the pelvic floor 
(Figure 1.1). Region 1 is the pubovisceral muscle, which is comprised of fatigue-
resistant (type I) muscle fibers that begin at the pubic bone on both sides of the 
symphysis and connect to the walls of pelvic organs and the perineal body; these fibers 
assist in closing the opening in the levator ani through which the urethra and vagina 
pass, or urogenital hiatus. Region 2, the puborectal muscle, forms a sling around and 
behind the rectum, just near the external anal sphincter. Region 3 is the iliococcygeal 
portion, which forms a relatively flat, horizontal shelf spanning the potential gap 
between pelvic sidewalls and the sacrum (8).  The levator ani and coccygeus muscles 
are attached to the inner surface of the minor pelvis to form the pelvic floor. The pelvic 
floor fulfills multiple functions. For one, the contraction of the pubococcygeus muscle 
narrows the genital hiatus. Additionally, contraction of the pelvic floor leads to the 
elongation and elevation of the pelvic organs allowing for urinary and fecal continence 
(7).  
 4 
 
FIGURE 1.1. Transverse plane of pelvic diaphragm (9) 
 
 
1.2 Injury to the Pelvic Floor 
1.2.1 Pelvic Floor Disorders (PFDs) 
A pelvic floor disorder (PFD) occurs when the pelvic muscles and connective 
tissue in the pelvis weaken or are injured, this causes the pelvic organs to become 
displaced from their normal anatomical position (Figure 1.2).  PFDs often require 
surgical treatment, necessitating reinforcement of weakened tissues with a surgical 
mesh material. PFDs consist of a broad range of interrelated clinical conditions 
including pelvic organ prolapse, urinary incontinence, fecal incontinence, voiding 
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dysfunction, defecatory dysfunction, and sexual dysfunction (3), and are associated 
with a negative impact on a woman’s social, physical and psychological well-being. 
 
 
 
FIGURE 1.2. A uterine prolapse occurs when a woman's pelvic muscles and ligaments become 
weak, causing the uterus to drop from its usual position. This allows the neck of the uterus 
(cervix) to bulge down into the vagina (Courtesy of Cleveland Clinic). 
 
 Vaginal childbirth, surgical technique, and high body-mass index are the most 
consistent risk factors, with the number one risk factor being vaginal childbirth (8,10–
16).  In one study conducted by Ashton-Miller, none of the 80 nulliparous women 
serving as controls had injuries, thereby identifying birth as a cause of the type of 
levator ani muscle injury seen in women with pelvic floor dysfunction (8). Biological 
modifications that occur post-vaginal delivery during reproductive years can lead to 
increased problems later in their life that result in prolapse of pelvic organs and/or 
urinary incontinence (8,12,17). Developing a PFD significantly affects women’s quality 
of life and often result in the need for complex surgery that has an unfortunately high 
reoperation rate of approximately 30% (18). 
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1.3 Surgical Treatment Options 
Surgical management of PFDs have undergone several paradigm shifts over the 
last few decades (19). In an effort to improve outcomes in transvaginal prolapse repairs, 
multiple biologic and synthetic graft materials have been introduced to reinforce 
and/or replace native tissue (2,20). Studies have shown lower failure rates after surgery 
with urogynecologic mesh, as compared with the traditional repair—also known as 
native tissue repair—of pelvic organ prolapse (19,21–23). However, as compared with 
anterior colporrhaphy (repair of the vaginal wall), use of a typical trocar-guided mesh 
for cystocele repair resulted in higher short-term rates of successful treatment but also 
in higher rates of surgical complications and postoperative adverse events(21). The 
following sub-sections take a closer look at the types of mesh on the market and 
complications associated with them. 
 
1.3.1 Three Types of Surgical Mesh 
Women suffering from pelvic organ prolapse who fail or decline pessary usage 
are candidates for surgical treatment. Reconstructive surgery aims to re-position the 
prolapsed vaginal canal or organ while alleviating any associated pelvic symptoms (10).  
Synthetic, biological and mixed-type mesh are most often used as surgical 
treatment options (Fig 1.3) (24). Of the synthetic meshes, Type I polypropylene mesh is 
most commonly used. Polypropylene mesh is the oldest prolapse mesh on the market 
and has shown favorable clinical efficacy and advantageous tensiometric strength 
compared with other synthetic meshes (11,25)
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allows mesh to keep its strength for a long period of time. Conversely, macroporous 
polypropylene mesh has been shown to produce persistent mild inflammatory changes, 
in comparison with other synthetic meshes (26,27). Biological grafts are usually of either 
porcine or bovine origin, and mixed-type meshes have a synthetic polypropylene core 
with a biological collagen wrapping. Animal-derived biological mesh will degrade and 
lose strength over time. It is not intended to provide long-term reinforcement to the 
repair site and as a result not commonly seen for pelvic floor repair. As the material 
degrades, new tissue growth is intended to provide strength to the repair. Mixed-type 
meshes have a synthetic polypropylene core with a biological collagen wrapping. The 
morphology of two popular meshes is shown in Fig. 1.4.  
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FIGURE 1.3 Classification of surgical mesh materials (7) 
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FIGURE 1.4 Macroscopic analysis of commercially available mesh (A) Synthetic: Pelvitex™ 
(C.R. Bard, Covington, GA, USA) is marketed with a hydrophilic porcine collagen I coat atop 
polypropylene (28)(B) cross-section of PelvitexTM under SEM (29); (C) Mixed-type mesh: 
Popmesh™ (Caldera, Agoura Hills, CA, USA) is manufactured as an ultra-light-weight (19 g/m2) 
polypropylene material (28)  
A C 
B 
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1.3.2 Surgical Procedures for Pelvic Organ Prolapse (POP) 
There are several types of prolapse. Prolapse can affect the vaginal walls, or it 
can be of one of the pelvic organs: uterine prolapse, enterocele (prolapse of the bowels), 
cystocele (prolapse of the bladder), or rectocele (rectal bulging caused by wall 
weakness).  
For surgery with prolapse of the bladder, urethra, rectum, and small bowel, the 
surgeon makes an incision in the wall of the vagina and pulls together the damaged 
tissue in the area of the prolapsed organ and strengthens the wall of the vagina to 
prevent recurrent prolapse. For prolapse of the vaginal vault, an incision is made in the 
wall of the vagina and attaches the top of the vagina to the wall of the lower abdomen, 
to the spine in the lower back, or to the ligaments of the pelvis (see Fig 1.5).  
Surgery can be undertaken choosing either an abdominal or vaginal route. 
Although precise estimates of the proportion of procedures undertaken by each route 
are not available, many have suggested that the preferred route for most prolapse 
surgery is vaginal, with as many as 80–90% of operations done this way (18,30,31). 
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FIGURE 1.5. Polypropylene mesh is placed over the anterior and posterior vaginal walls and then 
sutured to the anterior sacrum.  
 
 
1.4 Complications with Urogynecologic Surgical Mesh  
Since 11% of American women will require a primary operation for a pelvic 
organ prolapse (POP) by the age of 80 and almost a third of these women need a second 
surgery due to recurrence of prolapse and associated complications, urogynecologic 
mesh has received a lot of attention in recent years (18). Mesh use in POP has rapidly 
increased in recent years due to the high recurrence rate after native tissue repair. 
However, complications and recurrence of prolapse are still commonly observed with 
mesh implantation, especially with the transvaginal approach (32,33). Complications 
resulting from mesh implantation include shrinkage, erosion, exposure, dyspareunia, 
discomfort, the inability to walk, and inguinal and gluteal pain. Such complications are 
significant enough that both USA’s Food and Drug Administration (FDA) and UK’s 
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National Institute for Health and Clinical Excellence (NICE) have issued multiple 
warnings regarding the use of synthetic mesh in vaginal surgery for pelvic floor 
reconstruction (24,34,35). 
Despite its prevalent usage, urogynecologic meshes have had little regulatory 
oversight. Federal laws have mandated that meshes used in pelvic surgery are not 
subject to the lengthy and more thorough pre-market approval and are instead 
considered 510 (k) devices due to the fact there is a predicate, i.e., a device that is based 
on a similar device that was in use prior to 1976—in this case, hernia meshes (36).  
 
1.5 Evaluating Urogynecologic Mesh on the Market 
Most of the scientific work in the field of mesh for pelvic floor repair or hernia 
repair has been directed towards clinical outcome, especially recurrence rate, bio 
integration, tissue compatibility, and surgical technique (27,37–42), with the majority 
focusing on microscopic tissue reaction. Although host response is clearly an important 
consideration, any variance between the biomechanical properties of implant and 
surrounding tissue is likely to influence the likelihood of erosion. In recent years, there 
has been a push to understand more of the biomechanical features of the abdominal 
wall itself, with the first study being published in 2003.  
1.5.1 Evaluation of Biomechanical Properties  
The main function of surgical mesh is to provide reinforced support to the 
damaged tissues with mechanical strength similar to the undamaged native tissue (43–
45). Thus, they are a direct reflection of the composition and microstructural 
arrangement of a tissue, i.e. they provide quantitative information about the tissue 
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quality. Just as there are many different approaches to determine the structural 
properties of a complex of tissues, there are also many testing methodologies that can 
be used to determine the mechanical properties of a specific tissue (3). Tests include 
uniaxial tensile testing, suture pull-through strength, burst strength, and tear resistance 
(46). Uniaxial tensile testing, whether cyclical or not, has been the most commonly used 
tool to compare mechanical properties of urogynecological mesh (3,47).  
 
1.5.2 Histological Outcomes 
A multitude of studies have evaluated histology after implantation of scaffolds 
and mesh materials (39,42,44,48–57). De Tayrac et al. looked at collagen-coated vs. non-
coated low-weight polypropylene meshes in a sheep model for vaginal surgery (29). 
Post-implantation results showed that there were no differences observed between the 
two meshes in terms of shrinkage, tissue ingrowth, inflammatory response, and 
position of the mesh in the vaginal wall. In vivo studies have shown that polypropylene 
coated with natural polymers exhibits better tissue incorporation within the pores, less 
mesh contraction (40,58), and reduced the risk of vaginal erosions (41,59,60). However, 
none of the coatings have shown improved integration with the surrounding native 
tissue, i.e., muscle (61–63). Currently, a mesh that, when implanted, allows for muscle 
tissue ingrowth, contractility, and matches the mechanical integrity of native tissues 
without significant granulation tissue and or fibrosis remains an area of significant 
clinical interest. 
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1.6 Re-establishing Muscle Contractility 
While the reason for complications is unknown, most researchers hypothesize 
that one factor contributing to failure is stiffness. While stiffness means increased tensile 
strength, it occurs at the expense of tissue function with accelerated tissue contraction, 
decreased elasticity and compliance, and deterioration of smooth muscle function. After 
implantation of mesh, substantial fibrosis and little to no smooth muscle ingrowth are 
commonly observed around the vagina wall.  
Therefore, there is incentive to reduce aspects of the foreign body response and 
improve upon tissue integration after insertion of mesh (64). Previous research 
conducted on ventral hernia repair indicated that biomaterials have the ability to reduce 
fibrosis and improve native tissue integration. With native tissue ingrowth into the 
mesh, a re-establishment of the contractility of the smooth muscle will be possible. The 
science based approach to evaluation and modulation of the host tissue response to the 
chitosan coating and the PP mesh has the potential to significantly affect the design of 
next generation mesh materials and improve outcomes in pelvic floor repair.  
 
1.7 Introduction to Chitosan 
 It is widely believed that the ideal scaffold material for pelvic floor repair should 
be one that closely mimics the extra-cellular matrix (ECM), promotes muscle growth, 
and inhibits fibrosis. In biological organisms, the substrate for most cells is the ECM 
(65). The ECM adheres to cells with integrins, which are membrane-spanning 
heterodimeric receptors. Through this adhesion, the ECM regulates cell growth, cell 
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proliferation, cell differentiation, and matrix remodeling to the cells (65).  
There has been a shift towards coating polypropylene mesh with biological 
materials such as collagen, alginate, and fibrin in recent years(66–68). The mesh and 
biofilm composite provides a polypropylene skeleton for mechanical support with a 
biofilm that is believed to minimize both inflammatory response and fibrosis. However, 
reviews have been a mixed response with heavy lot-to-lot variation and difficulty 
controlling the mechanical properties of the neo-tissue after implantation of mesh. 
Chitosan-based biomaterials may be ideal candidates for use in coating surgical mesh 
materials. In addition to being inexpensive and easy to handle, the physical properties 
of chitosan can be altered by changing the deacyetylation percentage and molecular 
weight. Chitosan is produced commercially by deacetylation and depolymerization 
of chitin, which is a structural polymer that makes up the exoskeleton of crustaceans. It 
is composed of poly-N-acetylglucosamine units bound by β-1, 4 glycosidic bonds as a 
linear polymer of 2000-3000 units (69).. The most prevalent chitosan used for 
biomaterial applications is 85% deacetylated with 600,000-800,000 molecular weight. 
Mechanistically, addition of chitosan, may provide much more amino groups for 
cell adhesion and proliferation due to the affinity between positively charged 
ammonium groups of chitosan and negatively charged cell membrane surfaces (70). 
Muzzarelli et al. found that chitosan stimulates wound healing and increases 
angiogenesis; due to integrin engagement and improved expression of cytokines and 
growth factors. This has broad implications in a clinical context but also as a tool to 
distinguish the molecular mechanisms regarding cell–cell and cell–matrix interactions 
in the course of wound healing (71). 
  The polysaccharide chitosan has been found to be a effective material in a broad 
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spectrum of applications due to its unique biological properties including nontoxicity, 
affinity for protein adsorption, antibacterial, fungistatic, and anti-tumoral properties 
(72).  When applied to dermal wounds, chitosan was observed to decrease fibroblast 
infiltration and fibrosis (73), eliciting a more "constructive" response rather than the 
typical fibroplasia type response observed upon implantation of synthetic materials 
(69). Other studies have shown that chitosan can serve as a construct for smooth muscle 
ingrowth, but further work is needed to understand chitosan’s effect on muscle 
contractility, matching mechanical properties of native tissue, and inflammatory 
response (74).  
  Additionally, chitosan can be formed as interconnected-porous structures by 
freezing and lyophilization of chitosan solutions. The porous nature of the resulting 
chitosan scaffold is desirable because it allows for cells migrate and proliferation not 
only on the surface, but also within the bulk of the material (72). Creating a three-
dimensional inter-connected pore architectures at the microscale level has been shown 
in multiple applications to reduce the typical fibroplasia observed following the 
implantation of a number of common synthetic polymers (75). 
 
1.8 Overview and Study Objectives 
The objective of this research was to establish the effects of chitosan on 
polypropylenes mesh both in vitro and in vivo. First, we looked at attachment of 
fibroblasts and myoblasts on chitosan-coated polypropylene mesh and polypropylene 
mesh in vitro. We developed various concentrations of chitosan coatings and were able 
to characterize the mesh samples using Fourier transform infrared spectroscopy.  We 
harvested myoblasts and fibroblasts from neonatal mice and seeded them 1:1 atop the 
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mesh samples and analyzed the cell growth and ratio of cell types. Second, we took the 
mesh samples and implanted them in a rat abdominal wall model and looked a variety 
of different metrics: tetanic force generation, histological assessment, myogenin 
expression, macrophage typing, mechanical strength, and the collagen I/III content and 
ratio. The following specific aims were examined: 
 
1.8.1 Objective I 
Specific aim 1 (Chapter 2): To measure cell attachment of a co-culture of myoblasts 
(myo) and fibroblasts (fb) on mesh samples developed for muscle tissue ingrowth. 
 
 In this study, we hypothesized that coating polypropylene mesh with chitosan 
will preferentially enhance the attachment of myoblasts in co-culture with fibroblasts. 
We found that application of a 0.5% (w/v) chitosan-coated polypropylene elicited 
preferential attachment of myoblasts over fibroblast attachment in vitro. This was the 
first study of its kind to use the ratio of myoblasts to fibroblasts as a metric for 
evaluation. This study makes up the first half of Chapter 2.  
 
1.8.2 Objective II 
Specific aim 2 (Chapter 2): Determine if chitosan encourages functional muscle growth 
and lessens typical fibroplasia observed following the implantation of polypropylene in 
vivo.  
 
We hypothesized that chitosan-coated polypropylene mesh will promote muscle tissue 
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ingrowth and decrease inflammatory response in a rat abdominal wall model. We 
found that chitosan-coated polypropylene mesh promotes tissue ingrowth: 
• Functional muscle testing show 0.5% chitosan-coated polypropylene mesh 
generates significantly higher tetanic force than polypropylene mesh 
• Neo-tissue surrounding Ch-PPM was characterized by myogenin expression 
between mesh fibers as opposed to polypropylene and collagen-polypropylene 
mesh samples 
Additionally, chitosan-coated polypropylene mesh induced moderate inflammatory 
response: 
• Histology showed narrow band of fibrosis, high number of macrophages 
• Characterized by early presence of macrophages (Type M2) that have been 
shown to lead to better remodeling outcomes 
This study makes up the second half of Chapter 2.  
 
1.8.3 Objective III 
Specific Aim (Chapter 3): Examine the neo-tissue surrounding three different mesh 
samples to evaluate muscle tissue strength and collagen incorporation in a rat 
abdominal wall model. 
 
We hypothesized that a reduction in the ratio of collagen types I/III of the neo-tissue 
results in a structurally weaker tissue. The results of this study indicate that there is no 
significant difference in the ratio of collagen type I/III based on area or the absolute 
quantity of collagen types in mesh samples at either 4 weeks or 12 weeks. We do not 
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believe there is a relationship between the amount of collagen I/III ratio and mechanical 
strength in our samples, rather mechanical strength could be dependent on the cross-
linking and structure of collagen fibers. This study is described in Chapter 3. 
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Chapter 2  
 
Measuring the attachment of myoblasts on 
chitosan-coated vs. non-coated polypropylene 
mesh in vitro1 
 
2.1 Introduction 
Use of a knitted mesh is a common method indicated for mechanical 
reinforcement for abdominal hernia reconstruction and pelvic organ prolapse repair (1). 
Recurrence of ventral hernias after open suture repair can occur with a reported 
frequency of 31-49% when performed without mechanical reinforcement provided by 
the mesh (37).  At least 29% of those that opt for surgery of pelvic organ prolapse and 
incontinence will require re-operation (18). When used as a mechanical reinforcement in 
functional muscle repair, a synthetic mesh is intended to serve as a permanent implant, 
which remains in the patient for life (34,38). Synthetic mesh, such as polypropylene 
mesh, is widely used due to its high strength. However, although the use of synthetic 
mesh materials significantly reduces recurrence rates by providing strong mechanical 
                                                
1. 1 Udpa N., Iyer S.R., Rajoria R., Breyer K.E., Valentine H., Singh B., McDonough S.P., Brown 
B.N., Bonassar L.J., Gao Y. "Effects of chitosan coatings on polypropylene mesh for implantation 
in a rat abdominal wall model", Tissue Engineering. Accepted. 
DOI: http://online.liebertpub.com/doi/pdf/10.1089/ten.tea.2012.0739  
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support to abdominal wall or pelvic floor, commonly used synthetic polymers can 
sometimes elicit a strong foreign body reaction, often resulting in fibrous tissue 
encapsulation, erosion, or mesh degradation with high infection rates (76,77). These 
common outcomes following mesh implantation can result in discomfort for the patient 
and, in some cases, a need for revision or removal of the implant. The complications are 
significant enough that FDA issued warnings in 2007 and 2011 regarding the use of 
polypropylene mesh on the pelvic floor.  
Therefore, there is incentive to reduce aspects of the foreign body response, 
characterize macrophage phenotype, and improve upon tissue integration after 
insertion of mesh (56,64,78).  An ideal mesh for use in abdominal hernia repair and 
pelvic floor reconstruction would provide strength and elasticity similar to native 
tissues, i.e., muscle tissue, as well as elicit tissue incorporation in place of fibrous tissue 
ingrowth and be resistant to infection (60,79,80). Progressive ingrowth of fibrous tissue 
inhibits the integration of the implanted material within the tissue of interest and leads 
to a mismatch in mechanical properties with native tissue.  Ideally, the mechanical 
properties of the neo-tissue should be strong enough to prevent recurrence, but not so 
strong as to reduce compliance of the abdominal wall or the vaginal tissue and cause 
adhesion formation or unpredicted mesh shrinkage (44). This often results in pain or 
discomfort, which may require corrective surgeries due to complications including 
mesh erosion and mesh exposure. Materials, which preferentially promote the 
attachment of myoblasts over fibroblasts, may elicit a less fibrotic host tissue response in 
vivo. 
Chitosan-based biomaterials may be ideal candidates for use in coating hernia 
and pelvic floor mesh materials. The polysaccharide chitosan has been shown to be an 
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effective biomaterial in a broad spectrum of applications due to its unique biological 
properties including nontoxicity, affinity for protein adsorption, antibacterial, 
hemostatic, fungistatic, and anti-tumoral properties (72). Additionally, the physical and 
chemical properties of chitosan can be tailored to specific applications by relatively 
simple alterations the molecular weight and deacetylation percentage (72). Previous 
work has highlighted mechanical properties (57,81) or inflammatory response (38,81–
83) of chitosan-based materials in abdominal wall models of small animals, however 
there is no report describing the effect of chitosan-coated mesh on functional muscle 
tissue ingrowth. Given that hernia is induced by damages to the abdominal wall 
skeletal muscle, inflammatory response and tissue rebuilding to implantation of 
surgical mesh should include skeletal muscle ingrowth. We believe that by analyzing 
the skeletal muscle functionality, i.e., active muscle force generation, data that is more 
physiologically relevant for repair can be provided.  
The objective of our study is to examine the effects of chitosan coatings on 
polypropylene mesh. We hypothesized that the chitosan coating will promote muscle 
tissue ingrowth and decrease the inflammatory response. Both in vitro and in vivo 
studies were conducted to test this hypothesis. In the in vitro study, 1:1 co-culture of 
myoblasts and fibroblasts showed preferential attachment of myoblasts over fibroblasts 
to chitosan-coated polypropylene mesh. The in vivo study was performed in an 
established rat model of abdominal wall defect repair (63). The functional muscle 
response, histologic response and macrophage phenotype of the reconstructed tissues 
were examined at 2, 4, and 12 weeks post-implantation.   
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2.2 Materials and Methods 
2.2.1 Overview of Experimental Design 
All procedures were performed in accordance with the National Institute of 
Health (NIH) guidelines for care and use of laboratory animals, and with approval of 
the Institutional Animal Care and Use Committee (IACUC) at Cornell University. The 
study involves both in vitro and in vivo experiments. The in vitro study was performed 
using a reference polypropylene mesh (Avaulta Solo®, C.R. Bard) and different 
concentrations of chitosan coatings on polypropylene mesh. The mesh coated with 
chitosan that maximized cell attachment and yielded a high myoblast to fibroblast 
ingrowth ratio was selected for the in vivo study. In the in vivo portion of the study, an 
additional mesh was added, a monofilament polypropylene mesh coated with 
hydrophilic porcine collagen (PelvitexTM, C.R. Bard Inc., Covington, GA, USA). 
 
2.2.2 Preparation of Chitosan-coated Meshes and Characterization 
High molecular weight chitosan, >75% deacetylated, ~600,000 MW (Sigma 
Aldrich, Milwaukee, WI) was added to distilled H2O at concentrations of 0.3%, 0.5%, 
and 0.7% (w/v) and 1% (v/v) acetic acid solution until a clear solution was obtained. 
The sterile PPM was cut into 1.2 x 1.2cm squares and placed into a sterile bottle 
containing the 0.2"m-filtered chitosan-solution and stir bar. The mesh was removed 
from the solution, placed in a centrifuge tube, and left in liquid nitrogen for several 
hours while being placed in the lyophilizer at -40°C for 24 hours.  Mesh were sterilized 
under ultraviolet light for 20 minutes.  Scanning electron microscope (Leica 440, Buffalo 
Grove, IL) and Fourier transformation infrared spectroscopy (Bruker Vertex 80v, 
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Billerica, MA) using Opus 6.0 Software was used to confirm the successful coating. PPM 
was also subjected to the same coating procedure minus the addition of chitosan to 
ensure that procedural effects to do not alter the structure of the PPM material. Pore 
diameters were measured from the SEM images using ImageJ 1.45s (NIH, 2009). A 
representative mesh of each Ch-coated mesh type was selected, imaged, and 10 chitosan 
pores were selected at random for measurement.  The range was recorded. 
 
2.2.3 Overview of in vitro Study 
Neonatal and adult CD-1 mice (Charles River Laboratories International, Inc., 
Wilmington, MA) were sacrificed for isolation of myoblasts and dermal fibroblasts, 
respectively.  Isolation of cell types was modified from pre-existing protocol (84).  Cells 
were independently passaged to four generations, stained with a long-term lipophilic 
tracer and then seeded 1:1 atop one of four different test articles: polypropylene mesh 
(PPM), 0.3% Chitosan coated PPM (Ch-PPM), 0.5% Ch-PPM, and 0.7% Ch-PPM.  The 
mesh samples were imaged at 12 hours, 24 hours, and 48 hours.  
 
2.2.4 In vitro Immunocytochemistry & Co-culture 
Isolation of myoblasts and fibroblasts from mice and appropriate cell culture 
mediums were adapted from pre-existing protocol (84). At Passage 4, a sample of 
myoblasts and a sample of fibroblasts were seeded separately on glass slides and 
prepped for immunocytochemistry.  All staining procedures were followed according 
to vendor instructions (Abcam, Cambridge, MA).  After a DAPI stain, the primary 
antibodies used for antibody labeling were [1] rabbit polyclonal anti-desmin (Abcam) at 
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1:80 dilution for identification of myoblasts, and [2] rabbit polyclonal anti-fibroblast-
specific-protein-1 (Abcam) at 1:40 dilution for identification of fibroblasts.  The 
secondary antibodies used were [1] goat polyclonal secondary antibody to rabbit (FITC) 
at dilution 1:1000, and [2] goat polyclonal secondary antibody to mouse (TRITC) at 
dilution 1:1000, respectively. Plates were viewed with an inverted microscope 
(Olympus IX-71, Tokyo, Japan), and images were recorded using CellSens software. The 
images were overlaid, and the numbers of Desmin+/DAPI+ and FSP1+/DAPI+ cells 
were determined in four random quadrants per dish. If cells were determined to be 
>95% pure, the cells remaining in culture were stained with long-chain carbocyanines: 
fibroblasts were stained with DiI (Invitrogen) and myoblasts were stained with DiO 
(Invitrogen) following instructions provided by the vendor.  Following determination 
of purity of the desired cell culture, myoblasts and fibroblasts were seeded onto the 1.2 
x 1.2 cm mesh samples at a cell density of 2.4x105 cells/cm2.  To increase wettability, all 
mesh samples were soaked in media for 1 hour prior to cell seeding.  
 
2.2.5 In vitro Characterization of Cell Attachment on Mesh 
An IX-71 Olympus microscope was used to determine the ratio of the area and 
number of myoblasts and fibroblasts at 12, 24, and 48 hours. To image the mesh, 40x 
magnification was used.  Each mesh was analyzed for cell numbers and cell area.  The 
location chosen for imaging remained consistent amongst all mesh samples (identical 
weave pattern). Images were captured highlighting the fluorescent markers for 
myoblasts and fibroblasts, and cell area was determined by dividing the number of 
fluorescent pixels by the total number of pixels in the digital image. Total numbers of 
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each cell type were evaluated using ImageJ 1.45s (NIH, 2009). To confirm that chitosan 
remained on coated mesh samples for the duration of the in vitro study FTIR analysis 
was conducted again after 48 hours of the mesh being submerged in media.  
 
2.2.6 Overview of in vivo Study  
Male Wistar rats (Charles River Laboratories International, Inc.) between 250-450 
grams were randomly assigned to nine groups of six each. Each rat was subjected to a 
partial thickness excision of a 1.2 cm x 1.2 cm section of the ventrolateral abdominal 
wall musculature on either side of the linea alba. The defects were repaired with one of 
three test articles: Ch-PPM, collagen coated-PPM, or Col-PPM (PelvitexTM), and PPM 
alone. The animals were randomly divided into 3 groups after surgery for survival of 2, 
4, and 12 weeks. The harvested tissues were evenly split for measurement of active 
muscle force by contractile test, histological analysis, and macrophage phenotyping. 
Native tissue was also tested as a baseline control. 
 
2.2.7 In vivo Surgical Procedure 
Each rat was placed in a transparent plastic anesthesia induction chamber to 
administer inhalation anesthesia with 2.5% isoflurane and an oxygen flow rate of 1 
L/min. The ventral abdomen was clipped from the xiphoid process to the pubis, and 
sterile prepped with povidone-iodine scrub and warm saline. The animal was then 
transferred to the surgical table with a sterile drape applied over the ventral abdomen 
for a surgical procedure adapted from a well-established model (63).  A 4cm ventral 
midline abdominal skin incision was made, and the skin and subcutaneous tissue were 
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separated from the underlying musculature. Bilaterally, a 1.2 cm x 1.2 cm section of the 
external and internal abdominal oblique layers of the ventrolateral abdominal wall was 
excised while the underlying transverse abdominus and peritoneum remained intact.  
Different test articles were placed in the ventrolateral defects and oriented with the 
weave pattern perpendicular to the linea alba. The defect was repaired with a size-
matched piece of the chosen test article that was randomly selected prior to surgery.  
PROLENETM sutures (Ethicon Inc., Somerville, NJ) were placed at each of the four 
corners of the test article to secure the mesh to the surrounding musculature. A 
MONOCRYLTM suture (Ethicon Inc.) was used to close the skin incision.  Each animal 
was recovered from anesthesia and returned to the housing unit. Each rat received 
meloxicam by subcutaneous injection on the day of surgery and for two additional 
days.  The general health status and surgical site were monitored daily and recorded for 
the duration of the study. 
 
2.2.8 In situ Force Generation Testing 
Force generation tests were included to evaluate functional muscle tissue 
ingrowth in neo-tissue. In the first group, the rats were anesthetized by isoflurane 2, 4 
or 12 weeks after insertion of surgical mesh, and placed on an in-situ mounting 
apparatus. The skin and the underlying connective tissue were cleared from the surgical 
mesh placement site.  The four visible PROLENETM sutures, previously used to attach 
the surgical mesh to the partial defect, identified surgical mesh placement site. The tests 
to determine the contractile property of the tissue were adapted from the protocol 
previously described by Valentin, et al (2010), using a muscle testing system (Aurora 
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Scientific Inc., Toronto, Canada).  
After creating a tissue flap, in order to perform the testing across the muscle 
sections uniformly, the resting tension was set at approximately 2g before testing. The 
tetanic force was generated at this length with electrical stimulation for one second at 
frequencies of 30, 60, 70, and 80 Hz with a rest period of two minutes following each 
tetanic force generation. The maximum tetanic force generation for each frequency was 
recorded by averaging the tetanic force generation of the muscle from 0.1 second after 
start of stimulation to 0.1 second before end of stimulation, subtracted by the resting 
tension.  
 
2.2.9 Histology 
In the second group, after rats were euthanized, constructs were dissected off 
and split into two sets, for I) H&E staining and II) macrophage phenotyping and 
myogenin expression.  The first set was fixed by immersion in 10% neutral buffered 
formalin, embedded in glycol methacrylate (GMA), sectioned at 3 um and stained with 
hematoxylin and eosin (H&E).  A board certified veterinary pathologist (SPM), who 
was blinded to the treatment groups, examined the H&E stained mesh constructs by 
light microscopy. The severity of the inflammatory response was assessed using a well 
established grading scheme (Table 2.1) with minor modifications (85,86):  the width of 
the inflammatory reaction and scar were measured on a digital image of each slide 
created with an Aperio ScanScope microscope slide scanner (Carlsbad, CA).  The ruler 
tool in the Aperio ImageScope v9.1.19 software was calibrated using a digital image of a 
1 mm calibration slide (Carl Zeiss, Oberkochen, Germany).  The average width of the 
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inflammatory reaction or scar obtained from a total of 10 sections selected at random 
along the length of the construct was used in the tissue reaction-scoring scheme. Each 
sample received a scoring outcome of mild, moderate, or severe inflammatory response. 
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TABLE 2.1. Method of semi-quantitative histopathological assessment 
1.!!Tissue!reaction!scoring!Tissue!Reaction!Element!! ! !!!!!!!!!!!!!!!Grading!Factor!x!Weight!Factor!=!score!Width!of!inflammationa! ! ! ! ! ! ! 5! =! !Width!of!scara! ! ! ! ! ! ! ! 1! =!Overall!density!of!cellular!reactionb! ! ! ! ! 5! =!Number!of!cellsa!! Neutrophils! ! ! ! ! ! ! 6! =!Lymphocytes! ! ! ! ! ! ! ! 2! =! !! Plasma!cells! ! ! ! ! ! ! 2! =! !! Eosinophils! ! ! ! ! ! ! 1! =! !! Macrophages! ! ! ! ! ! ! 1! =!! Giant!cells! ! ! ! ! ! ! 1! =!! Fibroblasts! ! ! ! ! ! ! 1! =! !TOTAL!SCORE!!!2.!!Tissue!reaction!grade!Total!Score! ! Tissue!Reaction!Grade! ! ! Designation! ! !1L10! ! ! ! 1! ! ! ! ! Minimal!11L25! ! ! ! 2! ! ! ! ! Mild!26L40! ! ! ! 3! ! ! ! ! Moderate!!>40! ! ! ! 4! ! ! ! ! Severe!!a.!! Width!of!Inflammation!or!Scar! ! !!!!!! No.!Cells! ! !!!!!!!!! Grade!!!!!! (diameter!of!response!in!um)! ! !!!!! (per!60x!field)!! 0! ! ! ! ! 0! ! ! 0!! 1L200! ! ! ! ! 1L50! ! ! 1!! 201L400! ! ! ! ! 51L100! ! ! 2!! 401L600! ! ! ! ! 101L200! ! ! 3!! >600! ! ! ! ! >200! ! ! 4!! !b.!!! Overall!Density!of!Cellular!Reaction!(assignment!based!on!experience!of!pathologist)!!! Bare!scattering! ! 1!! ! ! ! 2!! ! ! ! 3!! Dense!aggregation! ! 4!
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2.2.10 Assessment of Macrophage Phenotype and Expression of Myogenin 
Macrophages have been described to have a spectrum of phenotypes, which 
range from classically activated and pro-inflammatory (M1) to alternatively activated, 
anti-inflammatory, regulatory and wound healing (M2).  Using the second set of the 
mesh used for histology purposes, the phenotype of macrophages responding to each 
mesh material were assessed as previously described (56) after embedding in paraffin.  
Briefly, histologic sections were de-waxed through immersion in xylenes and a graded 
series of ethanol (100-70%). Antigen retrieval was then performed by immersion in 10 
mM citric acid monohydrate (pH 6.0) at 95°C for 20 minutes.  The slides were allowed 
to cool and were then washed in TRIS buffered saline/Tween 20 solution (pH 7.4) and 
PBS.  The sections were then blocked in 2% normal horse serum, 1% BSA, 0.1% Triton 
X-100, and 0.1% Tween 20 in PBS (pH 7.4) for 1 hour at room temperature.  The sections 
were then exposed to antibodies specific for a pan-macrophage (M0) marker (1:50; 
mouse anti-CD68; Serotec), a M1 phenotype marker (1:50; rabbit anti-CD86; Abcam), 
and an M2 phenotype marker (1:50, goat anti-CD206; Santa Cruz) overnight at 4°C.  The 
slides were washed in PBS and then incubated in appropriate secondary antibodies.   
The secondary antibodies used were Alexa Fluor donkey anti-mouse IgG (594 nm; 
1:150; Life Technologies), Alexa Fluor donkey anti-goat IgG (488 nm; 1:150; Life 
Technologies) and donkey anti-rabbit IgG PerCP 5.5 (1:200; Santa Cruz).  The slides 
were then cover-slipped with aqueous mounting media containing DAPI.  
Representative sections from each sample group at the 14-day time point were 
examined and imaged by a blinded investigator using a Nikon e600 microscope 
equipped with a Nuance multi-spectral imaging system. 
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Myogenin is a part of the myogenic regulatory gene family, which includes 
MyoD, myf5 and MRF4. These genes encode a set of transcription factors that are 
essential for muscle development. Expression of myogenin is limited to cells of skeletal 
muscle origin(87). Additional sections were taken from the paraffin embedded blocks 
used for macrophage phenotype. These sections were stained with monoclonal mouse 
anti-myogenin clone F5D (Dako North America, Inc., Carpinteria, CA). All staining 
procedures were followed according to vendor instructions. Representative sections 
from each sample group were imaged at the 14-day time point. 
 
2.2.11 Statistical Analysis 
For in vitro results in Figure 2.3a, statistical significance (p<0.01) was calculated 
using a two-way ANOVA with mesh, time, and their interaction term as independent 
variables. Statistical significance (p<0.01) was calculated using a two-way ANOVA with 
mesh and time and their interaction term as independent variables. The interaction term 
was significant [F(6,24) = 21.67, n=3, p <0.001]. Differences between mesh samples at 
different time points were analyzed using a Tukey’s HSD post-hoc comparison (JMP, 
v.9).  All values are expressed as the least mean square mean ± standard deviation.  
For Figure 2.3b, statistical significance (p<0.05) was calculated using a two-way 
ANOVA with mesh and time and their interaction term as independent variables. 
Differences between mesh samples at different time points were analyzed using 
Tukey’s HSD post-hoc comparison. The analysis was done on a log-transformed 
dependent variable.  The interaction term was significant [F(3,16) = 23.36, p=0.0027]. 
Differences between mesh samples at different time points were analyzed using a 
Tukey’s HSD post-hoc comparison with a Bonferroni correction for multiple 
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comparisons. All values are expressed as the least mean square mean ± standard 
deviation.  
For in vivo results, in Figure 2.4, data was analyzed with JMP using a mixed 
model with random effect being the rat ID and the fixed effects being the mesh type. 
Both time and the interaction term of time and mesh type were independent variables. 
Statistical analysis was done using a mixed model with Tukey’s HSD post-hoc 
comparison (n = 4, p<0.05). Dashed line denotes force generation of native muscle 
tissue. All values are expressed as the least mean square mean ± standard error.  
 
 
2.3 Results 
2.3.1 Analysis of Mesh Materials by SEM and Fourier Transformation Infrared 
Spectroscopy (FTIR) 
Figure 2.1 shows the microarchitecture of the mesh materials as observed under 
SEM.  The polysaccharide was distributed within the interstices of the mesh fibers for 
the Ch-PPM samples.  The chitosan microarchitecture differed between 0.3%, 0.5% and 
0.7% Ch-PPM. The chitosan pore size of the different mesh samples varied. PPM has 
mesh pore sizes that measured 2.0 x 1.7 mm, the 0.3%, 0.5%, and 0.7% Ch-PPM has 
chitosan pore diameters within the polypropylene interstices that ranged from 200"m-
1.7mm, 80"m-140"m, and 10"m-60"m, respectively.  
As seen in Figure 2.2, the PPM exhibits peaks at 1375 cm-1 and 1450 cm-1 
representing the alkane groups, and at 2600-3000 cm-1 representing the methylene and 
methyl groups.  FTIR spectra of the Ch-PPM samples depict characteristic absorption 
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bands at 1089 cm-1, 1600-1750 cm-1, and 3370 cm-1, which represent glycosidic bonds, 
residual carbonyl groups, and the stretching vibration of the NH2 and OH groups, 
respectively.  These peaks were seen to increase with increasing chitosan 
concentrations. The FTIR after 48 hours results showed that: 1) after 48 hours, there is 
still chitosan attached to the mesh; and 2) the coating procedure does not affect the 
structure of PPM material. These two observations lead us to believe that the higher 
myoblast to fibroblast ratio is due to the chitosan coating.  
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FIGURE 2.1. Scanning electron microscope (SEM) micrographs of mesh types (A) Avaulta 
Solo® C.R. Bard, knitted polypropylene mesh (PPM), (B) 0.3% Ch-PPM, (C) 0.5% Ch-PPM, (D) 
0.7% Ch- PPM, (E) PelvitexTM, C.R. bard, collagen-coated polypropylene mesh (Col-PPM). 
Scale bar = 300 mm. Ch-PPM, chitosan-coated PPM. 
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FIGURE 2.2. FTIR spectra of high molecular weight chitosan (600,000 MW) and uncoated PPM, 
0.3% Ch-PPM, 0.5% Ch-PPM, 0.7% Ch-PPM. FTIR, Fourier transformation infrared 
spectroscopy. 
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2.3.2 Characterization of Cell Attachment on Mesh using Fluorescent Microscopy 
The ratio of myoblasts to fibroblasts on the surface of cell seeded mesh materials 
was measured using a pixel count of the DiO:DiI, respectively. By day 2, the total 
number of cells was significantly greater for all three Ch-PPMs than for the reference 
mesh (Fig. 2.3a). The ratio of myoblasts to fibroblasts for 0.3%, 0.5%, and 0.7% Ch-PPM 
consistently remained greater than 1 (Fig. 2.3b), indicating a higher number of attached 
myoblasts in comparison with fibroblasts both within the mesh interstices and atop the 
polypropylene fibers.  The control material had a ratio of less than 1, suggesting more 
fibroblasts attached than myoblasts.  
Statistical analysis of the same mesh across the three different time points was 
completed to analyze the proliferation of cells from 12 hours to 48 hours.  0.5% Ch-PPM 
at 48 hours was significantly different from the number of cells that attached to the 
same mesh at both 12 hours and 24 hours. The number of cells that attached to 0.5% Ch-
PPM at 24 hours was significantly different from the cells that attached at 12 hours. 
0.5% Ch-PPM was the only mesh to show a significant difference across the three time 
points. As a result, 0.5% Ch-PPM was selected for the in vivo portion of the study. 
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FIGURE 2.3. (A) Total number of cells attached to mesh samples. ‘‘*’’ indicates significantly 
different from control within time point, ‘‘ + ’’ indicates significantly different from 0.3% Ch-PPM 
within time point, ‘‘#’’ indicates significantly different from 0.5% Ch-PPM within time point, ‘‘%’’ 
indicates significantly different from 0.7% within time point, ‘‘a’’ indicates significantly different 
from 12-h time point within the same mesh type, and ‘‘b’’ indicates significantly different from 24-
h time point within the same mesh type. (B) The ratio of myoblast:fibroblast (myo/fb) for mesh 
samples. The ratio was measured using the DiO:DiI fluorescence ratio. ‘‘*’’ indicates significantly 
different from control within time point, ‘‘#’’ indicates significantly different from 0.5% Ch-PPM 
within time point, and ‘‘a’’ indicates significantly different from 12-h time point within the same 
mesh type. 
  39 
2.3.3 Analysis of Force Generation 
No significant differences were present amongst the different meshes after 2 
weeks and 4 weeks of implantation (Fig. 2.4). After 12 weeks of implantation 0.5% Ch-
PPM had significantly higher tetanic force response at stimulation frequency of 60 Hz 
than PPM.  PPM showed negligible contractile response at 12 weeks, while Ch-PPM 
approached native tissue better than the PPM and in terms of tetanic response at 12 
weeks.  Furthermore, contractile response of 0.5% Ch-PPM significantly increased 
between 2 weeks and 12 weeks; whereas there was no significant difference between 
PPM and Col-PPM. 
 
FIGURE 2.4. In situ force generation of mesh samples. Dashed line indicates force generation 
of native tissue. ‘‘ + ’’ indicates significantly different from 12-week PPM within time point, ‘‘a’’ 
indicates significantly different from 2-week Ch-PPM. 
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2.3.4 Histopathological Assessment 
Table 2.2 summarizes the histopathological assessment of the mesh samples after 
implantation in the abdominal wall.  At 2 weeks post implantation, the semi-
quantitative histopathological assessment for the degree and type of cellular infiltrate 
was moderate for all meshes.  The tissue reaction score for the Ch-PPM remained 
unchanged out to 12 weeks.  In contrast, the average tissue reaction scores for both the 
PPM and the Col-PPM increased at 12 weeks.  Although the average tissue reaction 
score for the Ch-PPM (35 ± 3.3) was not statistically significantly different from that of 
the PPM (p = 0.08) or the Col-PPM (p = 0.09) a clear trend was evident with a less 
intense tissue reaction induced by the Ch-PPM (Fig. 2.5a).  Strikingly, PPM at 12 weeks, 
was accompanied by locally extensive areas of dystrophic mineralization (Fig. 2.5b&c).  
No dystrophic mineralization was detected around any of the Ch-PPM.   The PPM was 
infiltrated by a large population of mixed mononuclear cells (Fig. 2.5b).  In contrast, the 
inflammatory infiltrate around the Col-PPM was similar to that around the Ch-PPM but 
with a moderately greater fibrotic response (Fig. 2.5c).  Figure 2.6 illustrates the stable 
tissue reaction to the Ch-PPM at 2, 4 and 12 weeks post implantation. 
!
  41 
 
 
TABLE 2.2 Mean rounded scores, width of inflammatory response, and width of fibrosis for each implanta 
 
aScores, width of the inflammatory reaction and the width of the fibrotic response (scar) for each 
time point were averaged and the mean rounded to obtain the final result (one SD). 
bTissue reaction scores: 0 = normal; 1–10 = minimal; 11–25 = mild; 26–40 = moderate; > 40 = 
severe.
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FIGURE 2.5. Comparison of representative tissue reactions to three test mesh articles at 12 
weeks of post-implantation. (A) Ch-PPM. (B) PPM (Avaulta Solo, C.R. Bard, Inc.). (C) Col-PPM 
(Pelvitex; C.R. Bard, Inc.). Ch-PPM (A) is embedded in a narrow band of fibrous connective 
tissue (black arrows) and the individual fibers are cuffed by a moderate number of macrophages 
(white arrow heads) and multinucleate giant cells (star). In contrast, the PPM has invoked a 
severe inflammatory reaction and a wide band of fibrosis (between black arrows) with large foci 
of dystrophic mineralization (blue arrows). Note the large clusters of plasma cells (black arrow 
heads) and the numerous multinucleate giant cells (stars). The Col-PPM (C) is embedded in a 
wider band of fibrosis compared to the Ch- PPM (black arrows), but only a few inflammatory 
cells are present. All images in the left hand column taken at 4x magnification; scale bar = 500 
mm. All images in the right hand column taken at 40x magnification; scale bar = 50 mm. 
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FIGURE 2.6. Tissue reaction over time to Ch-PPM. At 2 weeks (A) a thin layer of fibrosis (black 
arrows) and mixed inflammatory cells (white arrow heads), including neutrophils (green arrow 
heads), eosinophils (yellow arrow heads), macrophages (white arrow heads), and multinucleate 
giant cells (stars) surround the mesh. The degree of fibrosis is similar at 4 weeks (B) and 12 
weeks (C), but the number of inflammatory cells is decreased and consists almost entirely of 
macrophages with rare multinucleate giant cells. 
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2.3.5 Macrophage Phenotype and Expression of Myogenin 
Immunolabeling of representative sections from each sample group at 14 days 
post-implantation revealed qualitative differences in the phenotype of the cells at the 
interface with the mesh material (Fig. 2.7).  All samples were associated with a similarly 
intense infiltration of CD68+ macrophages at 14 days.  Both the PPM and Col-PPM 
groups were characterized by a predominance of CD86+ (M1 marker) cells both at the 
surface of the mesh and between mesh fibers.  The Ch-PPM group was characterized by 
qualitatively fewer CD86+ cells at the mesh surface and peripheral to mesh fibers.  PPM 
and Col-PPM samples were characterized by few CD206+ (M2 marker) cells at the mesh 
surface or between mesh fibers.  The Ch-PPM group was characterized by the presence 
of CD206+ cells both at the mesh surface and peripheral to mesh fibers.  
In Figure 2.8, immunolabeling of representative sections from each sample mesh 
type at 14 days post-implantation revealed qualitative differences in myogenin 
expression at the interface with the mesh material. Of the three mesh types, only the 
tissue samples with Ch-PPM were characterized with myogenin expression between 
mesh fibers.  Expression of myogenin is limited to cells of skeletal muscle origin.  
 
  46 
 
 
 
 
 
FIGURE 2.7. Immunolabeling of macrophage surface markers. Mesh materials were labeled 
with a pan macrophage marker (CD68, red), an M1 marker (CD86, yellow), and an M2 marker 
(CD206, green). All images taken at 40x magnification. Scale bar = 100 µm. 
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FIGURE 2.8. Immunolabeling of monoclonal mouse anti-myogenin of (A) Ch-PPM, (B) PPM, 
and (C) Col-PPM. Expression of myogenin (dark brown regions) is limited to cells of skeletal 
muscle origin and indicates early stages of muscle growth. Qualitatively higher amounts of 
positive stain of myogenin are seen in Ch-PPM (arrows). All images taken at 10x magnification. 
 
 
2.4 Discussion 
Implantable mesh materials for abdominal wall repair and pelvic organ repair 
should provide mechanical support and allow ingrowth of the surrounding tissues.  In 
hernia and gynecological surgery, integration of muscle tissue into the mesh is desired 
to accommodate the natural contractility of the muscle on the abdominal wall or the 
smooth muscle in the vagina. It has been shown that the strength of polypropylene 
mesh is advantageous in abdominal wall implantation (88). However, after 
implantation of the mesh, substantial fibrosis and little or no functional muscle 
ingrowth is commonly observed around abdominal wall and/or the vaginal wall, 
despite providing adequate mechanical strength at the time of implantation. This causes 
significant differences in material properties at the mesh-native tissue interface, which 
could result in stress concentrations and stress shielding effects, leading to mesh 
erosion. 
The objective of our study was to examine chitosan-coatings on polypropylene 
mesh to evaluate muscle tissue ingrowth and the inflammatory response. We 
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hypothesized that chitosan coating will promote muscle tissue ingrowth and decrease 
the inflammatory response. To test our hypothesis, an in vitro study was performed to 
determine the response of myoblasts and fibroblasts to different concentrations of 
chitosan coated on PPM. The in vitro results showed that the Ch-coating on PPM 
promotes myoblast and inhibits fibroblast attachment to the mesh. The in vivo study 
was then performed to further demonstrate that chitosan coating decreases 
inflammatory responses, promotes muscle tissue ingrowth and reduces fibrosis.  
Polypropylene and various concentrations of chitosan were studied in vitro after 
myoblasts and fibroblasts were seeded 1:1, which mimics the in vivo environment where 
muscle and collagen fibers co-exist.  A limitation of previous in vitro strategies for 
evaluating synthetic materials for muscle repair is their focus on a single cell type when 
evaluating the mesh materials.  Many studies concerned with muscle cell attachment on 
mesh scaffolds seeded solely fibroblasts or solely myoblasts on the mesh (68,89,90). We 
believe, a co-culture of primary cultures of myoblasts and fibroblasts provides better 
evidence of how a mesh will perform in vivo.  Preferential promotion of the attachment 
of myoblasts as opposed to fibroblasts in the co-culture environment may provide a 
better predictive metric to evaluate synthetic mesh materials in vitro. 
The in vitro results that show the chitosan coating on polypropylene promotes 
myoblast early attachment over fibroblast attachment is further supported by in vivo 
observation that Ch-PPM generates significantly higher tetanic force, indicating the 
ingrowth of muscle fibers.  The exact underlying mechanism of the effect is not clear. 
Diegelmann et al. postulate that one possible explanation may be related to 
microenvironment in response to chitosan (91).  In their study, fibroblasts that appeared 
in the chitosan-treated polyvinyl alcohol (PVA) sponges were smaller and more circular 
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compared to the spindle-shaped fibroblasts observed in the control wounds.  It is 
possible that chitosan may slow the attachment of fibroblasts.  The SEM analysis 
suggests that the microarchitecture of the chitosan polypropylene offers greater surface 
area for cell attachment and smaller pores for cell entrapment when compared to the 
reference mesh, which is supported by our observation that cells were observed atop 
the chitosan coating in our in vitro portion of the study. The polypropylene serves as the 
skeleton and reinforced structure for the cells, and the microporous architecture of the 
chitosan sponge allows for easy cell attachment atop the interstices of the 
polypropylene knitted mesh. We believe that the higher force generation seen in the 
neo-tissue associated with the Ch-PPM group is due to functional muscle tissue 
ingrowth.  As opposed to fibrotic tissue, functional muscle tissue will respond to 
electric stimulation to generate force. Both of force generation and assessment of 
myogenin expression confirm the ingrowth of muscle tissue in Ch-PPM. Other tissue 
integration will not cause such an enhancement. Additional studies are needed to 
understand how the number and arrangement of muscle fibers relate to in situ force 
generation observations. 
Chitosan scaffolds induce only a minimal inflammatory reaction in a rat model.  
Although the material recruits neutrophils to the site of implantation, the neutrophils 
are not activated and the material induces neither lymphocyte proliferation nor 
antibody responses (48). Histopathological assessment of Ch-PPM implants in the 
present study found a moderate accumulation of primarily macrophages and fewer 
multinucleated giant cells at the implant-tissue interface that was unchanged from 2 
weeks to 12 weeks post implantation.  In contrast, the tissue reaction to PPM at 12 
weeks consisted of a mixed mononuclear cell response that included varying numbers 
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of lymphocytes and plasma cells in addition to macrophages and multinucleated giant 
cells. Interestingly, at 12 weeks post implantation, a large sample of both the PPM and 
Col-PPM was surrounded by locally extensive areas of dystrophic mineralization, 
which was not observed around the Ch-PPM.  Dystrophic mineralization typically 
occurs in necrotic or degenerated tissues.  Our results suggest that chitosan coating 
alters the host immune response to the mesh resulting in decreased necrosis and tissue 
degradation. Further studies to confirm these observations and to elucidate the cellular 
and molecular mechanisms behind this change are needed. 
To investigate the histology further, we conducted analysis of the macrophage 
phenotype at the mesh interface at 14 days post-implantation.  A number of recent 
studies have demonstrated, despite the presence of large numbers of immune cells 
within the site of implantation at early time points (7-14 days post-implantation), some 
surgical materials are capable of promoting the formation of functional tissue while 
others elicit a foreign body reaction and tissue encapsulation.  It has been suggested that 
these divergent outcomes are related to phenotypic differences in the macrophage 
population.  The presence of a predominant population of M1 cells has been associated 
with poor remodeling outcomes, while M2 phenotype macrophages are associated with 
more integration and functional outcomes. Our results suggest that although a 
histologically similar population of predominantly mononuclear cells was observed at 
14 days, Ch-PPM samples elicit a decreased M1 and increased M2 phenotype as 
compared to PPM and Col-PPM samples.  These results are consistent with recent 
studies showing improved outcomes associated with materials which elicit an increased 
M2 response (56,75,92,93). These results coupled with the assessment of myogenin 
expression and the outcomes of the force generation testing favor Ch-PPM over 
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commercially available meshes. The mechanisms by which chitosan may alter the host 
immune response remain unclear, but appear to be associated with differences in long-
term histologic outcomes. 
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Chapter 3 
 
Biomechanical properties of mesh materials 
following implantation in the rat abdominal wall 
model2 
 
3.1 Introduction 
The 2005 National Health and Nutrition Examination Survey reports that the 
number of women in the United States with at least one pelvic floor disorder (PFD) will 
increase from 28.1 million in 2010 to 43.8 million in 2050 (94). Currently, women risk a 
7% chance of requiring surgery for pelvic organ prolapse by the age of 80 (18). Re-
operation, however, is common, with repeat cases reaching nearly 30% mainly due to 
complications of grafts used in female pelvic floor reconstruction (18). The magnitude of 
women who will be affected by PFDs emphasizes the importance of developing 
effective treatment strategies.  
Common treatment options for PFDs, such as pelvic organ prolapse and stress 
urinary incontinence, involve insertion of classic biomaterials such as polypropylene 
                                                
2 Udpa N., Iyer SR, McDonough SP, Gao Y. “Type I and III collagen and biomechanical properties of 
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(PPM) (25,34,46,58,59,64,79,95–100). High failure rates, reported up to 40%, are 
associated with commercially available mesh, which has been reported to elicit a strong 
foreign body reaction and incompatible mechanical strength leading to discomfort in 
women3 when performing daily activities such as exercise, coughing, laughing, etc. 
(9,29,101). The complications are significant enough that the FDA issued warnings in 
2007 and 2011 regarding the use of polypropylene mesh to treat PFDs (19,33,102).  
The main function of the mesh insertion for pelvic floor reconstruction is to 
provide mechanical support to the pelvic tissues and organs. However, meshes come 
with their own set of complications. One theory for mesh failure is that stiffer meshes 
may increase the likelihood of erosion, pain, and poor function (103). In recent years, 
the center of attention for stiffness studies has shifted to alterations of the extracellular 
matrix (ECM). As the major component of the ECM and because of its high mechanical 
stiffness, the content and the ratio of collagen types I and III have been assumed to 
correspond with the tensile strength and mechanical stability of both the connective 
tissues and the scar tissue induced (104–107). Early phases of wound healing are 
characterized by the abundance of type III collagen, which is mainly replaced by 
mature, fibrillar type I collagen during later stages(108). Biological tissues with a high 
proportion of collagen type I (e.g. tendon) are characterized by greater strength and 
stiffness, and tissues with high levels of collagen type III (e.g. skin) are characterized by 
low strength (109).  To avoid a mismatch of neo-tissue with native tissue, many studies 
have focused on evaluating the ratio of collages type I to type III to gain a sense of the 
                                                                                                                                                       
mesh materials following implantation in the rat abdominal wall model” (in preparation) 
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composition of the new tissue. With this in mind, researchers have suggested avoiding 
scaffolds and biological materials that elicit a low ratio of collagen types I to III as to 
indicate low mechanical strength and as a means to indicate people at high risk 
(104,110–112). However, more work is required to elucidate the relationship between 
the ratio of collagen types I and III and mechanical strength in urogynecologic meshes 
for pelvic floor repair. 
Previous studies have shown that chitosan, a cationic polysaccharide showing 
excellent cell adhesive properties, influence the ratio of collagen types I/III in keloid 
fibroblasts (71). Additionally, there has been an emergence of literature in evaluating 
chitosan-based biomaterials as candidates for use in hernia and pelvic floor repair 
(38,64,65,81). The polysaccharide chitosan has been shown to be an effective biomaterial 
in a broad spectrum of applications due to its unique biological properties including 
nontoxicity, affinity for protein adsorption, antibacterial, hemostatic, fungistatic, and 
anti-tumoral properties (72), additionally, when using N-carboxybutyl chitosan in 
wound management researchers have found that it becomes gel-like in contact with the 
wound fluids, providing a bio-layer which provides a protection of the newly-formed 
tissues (113). Additionally, in a previous study, our lab showed that chitosan coatings 
preferentially promote the attachment of myoblasts over fibroblasts, have been shown 
to elicit a less fibrotic host tissue response in vivo (114,115). 
The present study was designed to establish the relationship between collagen 
deposition and the mechanical properties of neo-tissue in a rat abdominal wall model 
after implantation of three different mesh types: a reference polypropylene mesh 
(Avaulta Solo®, C.R. Bard Inc., Covington, GA, USA), chitosan on polypropylene mesh, 
and a monofilament polypropylene mesh coated with hydrophilic porcine collagen 
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(PelvitexTM, C.R. Bard Inc.). The objective of our study was to 1) evaluate mesh strength 
and collagen incorporation after 4 and 12 weeks of implantation in a rat abdominal wall 
model and 2) determine the relationship between collagen deposition and mechanical 
strength of a chitosan-coated polypropylene mesh. We hypothesized that a reduction of 
the ratio between collagen types I and III of the neo-tissue results in a mechanically 
weaker tissue. 
 
3.2 Materials and Methods 
3.2.1 Overview of Experimental Design 
All procedures were performed in accordance with the National Institute of 
Health (NIH) guidelines for care and use of laboratory animals, and with approval of 
the Institutional Animal Care and Use Committee (IACUC) at Cornell University. Male 
Wistar rats (Charles River Laboratories International, Inc.), weighing 250–450 g, were 
randomly assigned to nine groups of six each. Each rat was subjected to a partial 
thickness excision of a 1.2 cm x 1.2 cm section of the ventrolateral abdominal wall 
musculature on either side of the linea alba. The defects were repaired with one of the 
three test articles: polypropylene mesh (PPM), chitosan-coated polypropylene mesh 
(Ch-PPM), and collagen coated PPM (Col-PPM). The animals were randomly divided 
into 3 groups after surgery for survival of 2, 4, and 12 weeks. The harvested tissues 
were evenly split for measurement of tensile strength by uniaxial tensile testing and 
collagen typing. Native tissue was also tested as a control. 
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3.2.2 Preparation of Chitosan-coated Meshes and Characterization 
To create and characterize the chitosan coatings we used the same methodology 
as described in an earlier publication (114). Briefly, we used high molecular weight 
chitosan, >75% deacetylated, ~600,000 MW (Sigma Aldrich, Milwaukee, WI) which was 
added to distilled H2O at a 0.5% concentration (w/v) to a 1% (v/v) acetic acid solution 
until a clear solution was obtained. The sterile PPM was cut into 1.2 x 1.2cm squares 
and placed into a sterile bottle containing the 0.2"m-filtered chitosan-solution and stir 
bar. The mesh was removed from the solution, placed in a centrifuge tube, and left in 
liquid nitrogen for several hours while being placed in the lyophilizer at -40°C for 24 
hours. The mesh samples were sterilized under UV light for 20 minutes. Scanning 
electron microscope (Leica 440, Buffalo Grove, IL) and Fourier transformation infrared 
spectroscopy (Bruker Vertex 80v, Billerica, MA) using Opus 6.0 Software was used to 
confirm the successful coating. PPM was also subjected to the same coating procedure 
ensure that the procedure does not affect the structure of PPM material. 
 
3.2.3 in vivo Surgical Procedure 
This procedure was described in a previous study from our lab (114) Each rat 
was anaesthetized using 2.5% isoflurane and an oxygen flow rate of 1 L/min. The 
ventral abdomen was clipped from the xiphoid process to the pubis, and sterile 
prepped with povidone-iodine scrub and warm saline. A 4cm ventral midline 
abdominal skin incision was made, and the skin and subcutaneous tissue were 
separated from the underlying musculature. Bilaterally, a 1.2 cm x 1.2 cm section of the 
external and internal abdominal oblique layers of the ventrolateral abdominal wall was 
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excised while the underlying transverse abdominus and peritoneum remained intact.  
Different test articles were placed in the ventrolateral defects and oriented with the 
weave pattern perpendicular to the linea alba. The defect was repaired with a size-
matched piece of the chosen test article that was randomly selected prior to surgery.  
PROLENETM sutures (Ethicon Inc., Somerville, NJ) were placed at each of the four 
corners of the test article to secure the mesh to the surrounding musculature. A 
MONOCRYLTM  suture (Ethicon Inc.) was used to close the skin incision.  Each animal 
was recovered from anesthesia and returned to the housing unit. Each rat received 
meloxicam and general health status and surgical site were monitored daily post-
implantation. 
 
3.2.4 Collagen Typing 
In the first group, after rats were euthanized, constructs were dissected off. The 
collected tissues with constructs were fixed by immersion in 10% neutral buffered 
formalin, embedded in glycol methacrylate (GMA), sectioned at 3 um and stained with 
picrosirius red using standard histological techniques.  Each section was examined by a 
board certified veterinary pathologist (SPM) who was blinded to the treatment groups. 
 The sections were analyzed using an Olympus BX41 microscope (Melville, NY, USA) 
equipped with filters to provide circularly polarized illumination and aligned so that 
the background in the field of view was as dark as possible (i.e. crossed polarized light 
illumination). Digital images obtained with a 10X objective lens and a digital camera 
(DP21, Olympus) were captured as TIFF files at 1600 x 1200 pixels at a resolution of 60 
pixels/cm and displayed on a high-resolution monitor (Dell 2408WFP). 
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To ratio the samples for the collagen type I/III ratios, a board-certified veterinary 
pathologist, blinded to the mesh samples evaluated the yellow pixels (collagen type I) 
and green pixels (collagen type III) using a proprietary color de-convolution algorithm 
(Aperio, Vista, CA, version 9.1) that separates the image into three channels that 
correspond to the colors of the stain used.  The input parameters, optimized according 
to the manufacturer’s instructions, for each color and the background (channel 1 = 
yellow, channel 2 = green and channel 3 = background) were as follows:  channel 1) red 
component 0, green component 0.062, and blue component 0.451, channel 2) red 
component 0.243, green component 0.12 and blue component 0.231 and channel 3) red 
component 0.402, green component 0.541 and blue component 0.567.  Four to eight 
regions within the interface were captured by the camera for each mesh sample and the 
collagen I/III ratios were obtained by analysis of the amount area of collagen type I and 
III. Results are expressed as a collagen types I/III. 
Additionally, for each sample we calculated the volume fraction of collagen type 
I and type III using the same de-convolution algorithm to determine the amount of 
collagen within the total area selected. Four representative regions per sample were 
selected. 
 
3.2.5 Uniaxial Tensile Testing 
In the second group, after the rats were euthanized, a uniaxial tensile test in the 
longitudinal direction was performed. After sacrifice, the samples were carefully 
dissected from the surrounding connective tissue and immediately stored at -80°C. On 
the day of testing, the tissue was cut using a custom-made dogbone punch 
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(length/width aspect ratio = 3) and thawed immediately before performance of the 
uniaxial tensile test in a water bath. Native tissue was dissected off the samples and 
soft-tissue clamps lined with sandpaper were utilized to grip each sample at the 
proximal and distal ends. Throughout the experimental protocol, the sample was kept 
moist using 0.5% saline. The distal end was attached to a 1kg load cell (Honeywell 
model 31, resolution 0.1 N; Sensotec, Columbus, OH) and secured to the base of the 
uniaxial testing machine EnduraTEC loading frame [EnduraTEC; Electroforce (ELF) 
3200 System, Minnetonka, MN]. The specimen was aligned with the loading axis of the 
machine. A small preload (0.1 N) was applied to the tissue and 10 cycles of 
preconditioning was performed at a rate of 10 mm/min. A load to failure test was 
performed immediately after the preconditioning, as previously described (76).  
Several metrics were collected: the load (force, N) and elongation (distension, 
mm) of the tissue were recorded and used to generate load-elongation curves, which 
were then converted to a stress-strain relationship to calculate the mechanical 
properties of the vagina in the longitudinal direction. Stress was defined as the load (a 
measure of the force applied to the tissue) divided by cross-sectional area, and strain 
was defined as the change in distance between the clamps divided by the original 
distance between the clamps (#l/l0). The slope of the linear region of the stress-strain 
curve was defined as the tangent Young’s modulus (a measurement of stiffness), while 
the ultimate tensile strength and maximum strain were recorded at failure (point at 
which the specimen breaks apart).  
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3.2.6 Statistical Analysis 
All data was analyzed with JMP (v.9) using a mixed model. Statistical analysis 
was done using a mixed model with student t-test comparison (n = 8, p<0.05). Fixed 
effects tests were done on mesh type, time, and mesh type cross time. Differences 
between mesh samples were analyzed using a student t-test with a Bonferroni 
correction for nine comparisons (4 weeks, 12 weeks, and comparisons between time 
points) in cases where there was significant difference (p-value < 0.05). All values are 
expressed as the least mean square mean ± standard deviation.  
 
3.3 Results 
 
3.3.1 Analysis of Collagen Typing 
The total volume fraction of absolute amounts of collagen types I & III deposited 
in the neo-tissue was similar [4 weeks: Ch-PPM (0.498±0.13), PPM (0.508±0.1), Col-PPM 
(0.419±0.08); 12 weeks: Ch-PPM (0.513±0.15), PPM (0.495±0.19), Col-PPM (0.577±0.34)]. 
There was no significant difference noted between mesh types or time points. This data 
is consistent with previous work shown in our lab shown in Table 2.2 in Chapter 2, 
specifically the width and amount of fibrosis for each implant. Table 3.1 summarizes the 
ratio of collagen type I/III of the mesh samples after implantation in the abdominal 
wall. Again, there was no significant difference between the mesh samples at both time 
points or between mesh samples; however, we witnessed a clear trend with 
incorporation of more collagen III, lower collagen type I/III ratio, from 4 weeks to 12 
weeks across all mesh types.  
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Figure 3.1 illustrates the picrosirius red staining of mesh samples at 4 and 12 
weeks post implantation.  
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TABLE 3.1 Ratio of collagen I/III ratios in mesh samples 
Group N = 4 weeks 12 weeks 
Ch-PPM 8 0.938±0.719 0.600±0.356 
PPM 8 0.663±0.531 0.327±0.239 
Col-PPM 8 0.637±0.294 0.826±0.486 
 
 
 
 
FIGURE 3.1. Mesh samples explanted after implantation. Visualization by crossed Polaroid 
filters allowed estimation of collagen type I, seen as thick yellow, orange or red colored fibers 
and collagen type III fibers are thinner and stained in pale green shades. Magnification 4x. 
Scale bar: 500 µm. Gray portions indicate native tissue. 
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3.3.3 Analysis of Uniaxial Tensile Testing 
The biomechanical properties of the urogynecologic mesh samples are reported 
in Table 3.2 and representative curves are shown in Figure 3.3 The curves exhibit a non-
linear shape, which can be divided into 3 regions: 1) the initial non-linear toe region; 2) 
the linear region; and 3) failure region. For all meshes, during pre-conditioning, the first 
cycle indicated a pronounced toe region (i.e., low stress), which lessened in the 
consequent cycles. At 4 weeks, we noticed that the onset of the linear region varied 
between mesh types. Col-PPM had a much larger toe region with the linear region 
starting at 25-60% strain in comparison with PPM and Ch-PPM, starting at 15-25% 
strain and 10-25% strain, respectively. It suggests that the collagen fibers may be kinked 
or may be orienting in a direction that is perpendicular to the longitudinal direction. At 
12 weeks, we notice that the PPM does not reach the linear region until 30-40% strain, 
while both Ch-PPM and Col-PPM have linear regions starting at 15-30% strain. 
No infection or erosion of any of the mesh samples occurred in the abdomen. 
There was no effect of time between samples. After 4 weeks of implantation, Ch-PPM (p 
= 0.001) and PPM had a significantly higher ultimate tensile strength in comparison 
with Col-PPM. At 4 weeks, Ch-PPM (p = 0.001) also had a significantly higher elastic 
modulus than Col-PPM. Between 4 and 12 weeks, Col-PPM is the only mesh sample 
that became significantly stiffer (p = 0.02). At 12 weeks after implantation, Ch-PPM was 
had a significantly higher ultimate tensile strength in comparison with PPM (p = 0.003) 
and Col-PPM (p = 0.02). Considerable variation in tensile properties with a mesh type 
may be related to the degree of degradation and host tissue incorporation. 
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TABLE 3.2. Comparison of tensile properties of neo-tissue after implantation of mesh at 4 and 12 weeks 
 ! Elongation at 
failure (%) 
Ultimate tensile 
strength (kPa) 
Elastic Modulus 
(kPa) 
Thickness 
(mm) ! 4 weeks 
     
Ch-PPM  55±7.0 1596.34±147.24γ 4674.83±2663.6 γ 0.45±0.15 
PPM  81±12.4 2125.29±588.03 γ 3388.20±567.36 0.49±0.15 
Col-PPM  88±29.2 813.02+235.97 2203.15±1107.7
8* 
0.36±0.11 
! 12 weeks 
     
Ch-PPM  68±17.9 4543.64±1254.18 β, γ 8264.1±1753.63 0.45±0.22 
PPM   75±8.9 2317.13±267.53 4469.53±909.86 0.42±0.07 
Col-PPM  76±20.7 2199.55±809.08 5005.68±614.57 0.43±0.17 
 ‘β’ indicates significantly different from PPM within time point; ‘γ’ indicates significantly 
different from Col-PPM within time point; “*” indicates significantly different from same mesh 
type at 12 weeks 
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FIGURE 3.3. Representative stress-strain curve of mesh samples. (A) Ch-PPM, PPM, & Col-
PPM at 4 weeks; and at (B) 12 weeks. 
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3.4 Discussion 
Mesh materials for repair of pelvic floor and hernia repair have become integral 
components in surgery and are nowadays regarded as standard procedures for 
treatment. Ideally, surgical mesh materials for hernia and pelvic organ repair should 
provide mechanical support, accommodate the natural contractility of muscle, and 
allow for adequate collagen deposition during wound healing (34).   
Within the first phases of wound repair processes, tissue formation is 
characterized by fibroplasia, neovascularization and ECM production. Later phases of 
wound repair are characterized by matrix remodeling with remodeling of initial 
granulation tissue into connective tissue. The initially abundant immature type III 
collagen is for the most part replaced by mature type I collagen during the physiological 
wound healing. The relative proportions of types I and III and distribution have been 
studied in a number of studies (112,116–120). It has been suggested that the presence of 
type III collagen and its relative proportion correlates with strength of the newly 
formed tissue, though to our knowledge, there have been no studies that have 
demonstrated the correlation between the mechanical strength experimentally in a 
single study(121). The objective of our study was to 1) evaluate mesh strength and 
collagen incorporation after 4 and 12 weeks of implantation in a rat abdominal wall 
model and 2) determine the relationship between collagen deposition and mechanical 
strength of a chitosan-coated polypropylene mesh. We hypothesized that a reduction in 
the ratio between collagen types I and III of the neo-tissue would result in a 
mechanically weaker tissue.  
Our results suggest that coating the meshes with biological materials does not 
significantly impact the collagen type I/III ratio. The determined ratio in our samples 
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illustrates that the primary collagen found in the implanted meshes is collagen type III 
in comparison with collage type I. Structures, like the pelvic floor, that necessitate 
distensibility, consist of predominantly collagen type III(47,118). Lehto et al. found that 
native rat abdominal wall muscle has a collagen type I/III ratio of 0.37, which is fairly 
close to the neo-tissue score surrounding PPM(122). These results are consistent with 
our previous study that showed using a semi-quantitative histopathological assessment 
to examine the fibrotic response of the three mesh types that there was no significant 
difference (114). Junge et al. have also shown no significant differences in the collagen 
type I/III ratio between mesh samples varying in pore diameter, weight, structure, and 
material in a rat abdominal wall model (123).  
We found that the Ch-PPM mesh is significantly stiffer than the commercially 
available meshes at both 4 and 12 weeks. The results of our uniaxial tensile testing for 
PPM and Col-PPM are consistent with literature(76). While there was no significant 
difference in elongation or thickness of newly formed tissue, we observed that Ch-PPM 
had a higher ultimate tensile strength at 12 weeks in comparison with PPM and Col-
PPM. This does not correlate with our data for the collagen type I/III ratio; therefore, 
we conclude that there is no relationship between the collagen type I/III ratio. As no 
significant differences are observed on absolute collagen content, the higher stiffness of 
Ch-PPM is not due to the absolute content of collagen in the mesh. Ideally, the strength 
and elasticity of surgical mesh materials used for pelvic floor repair should match the 
native tissue in order to support to pelvic organs and minimize erosion (76). In addition 
to collagen concentration, biomechanical properties also depend on cross-link density. 
Thus, high stiffness of neo-tissue with implanted Ch-PPM could be due to a higher 
cross-linking density (54,124).  
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The other possible reason for higher stiffness of Ch-PPM mesh could the 
orientation and geometry of the collagen fibers in the tissue. In many soft tissues, a 
nonlinear stress strain relationship is observed for all three types of mesh.  The stress 
strain curve is characterized by a toe region, in which the stiffness increases with 
increased strain, a linear region, and a failure region. The toe region suggests that the 
collagen fibers may be crimped or might be oriented in a direction that is perpendicular 
to the longitudinal direction(125). When the tissue is stretched, the collagen fibers 
straighten and reorient to the direction where the load is applied. When most the fibers 
are straight, and reoriented, the stress strain relationship becomes linear. Therefore, the 
size of the toe region indicates the waviness and orientation of collagen fibers in the 
tissue.  Our ex vivo uniaxial tensile tests showed that at 12 weeks, the PPM has a larger 
toe region with the linear region starting at 30-40% strain, while both Ch-PPM and Col-
PPM have linear regions starting at 15-30% strain, suggesting that the collagen fibers in 
Ch-PPM are either more straight or orient more along the direction that load applies. 
This is supported by previous studies that suggested chitosan is able to enhance 
vascularization and a continuous supply of chitoo-ligomers to the wound that stimulate 
correct deposition, assembly and orientation of collagen fibrils, and are incorporated 
into the ECM (71). Therefore, the high stiffness of Ch-PPM mesh could be due to the 
different range of the toe region suggested that the waviness and orientation of the 
collagen fibers.     
Coupled with our previous study, we believe that the additional mechanical 
strength found in samples implanted with Ch-PPM, could also be due to an increase in 
muscle fibers, which in addition to generate active muscle force, also contribute to 
passive mechanical strength. In our previous study, we have shown that chitosan 
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coating on tissue culture plates or polypropylene promotes attachment of myoblast in 
vitro (114,115).   We also showed that chitosan coating on polypropylene mesh promotes 
muscle tissue ingrowth in vivo, demonstrated by higher amounts of immunolabeled 
myogenin and higher muscle force generation in Ch-PPM samples after implantation in 
a rat model(114,115). Therefore, we believe that the muscle tissue ingrowth into the neo-
tissue surrounding the Ch-PPM mesh is also responsible for the higher elastic modulus. 
This is indirectly supported by a previous finding that when muscles are compromised 
by disease or age, damaged muscle fibers are instead replaced by infiltrating fibrous 
tissue or fat, leading to a net loss of muscle mass and as a result, a loss of strength(68). 
Limitations of this study exist. The circular polarized light technique we use to 
evaluate collagen deposition has its limitations. For one, it is only an estimation of the 
ratio of collagen types, in contrast to a biochemical analysis. Though this method is 
widely used and accepted, if polarized light is used, it is possible that some collagen 
fibers will not appear if they are aligned parallel to the transmission axis of either of the 
two polarizing filters. A rotating microscope stage can minimize this effect; however, 
collagen fibers are frequently crimped or wavy. Thus, some fibers will appear dark no 
matter how the microscope stage is rotated. Thus, total collagen content may be 
underestimated, especially in tissue containing large amounts of wavy fibers (126). 
However, we have minimized this effect by taking the ratio of the collagen types and 
we assume that both collagen I and collagen III fiber may not be visible to alignment 
with the transmission axis equally. Data from this study was obtained from a rat model 
using a relatively small sample size. In a review published by Goh (2003), the author 
discusses the limitations of the uniaxial tensile testing of mesh samples for prolapse 
repair, stating that the ultimate tensile strength is not the strongest indicator of whether 
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a mesh will fail since under normal physiological conditions the tissue may not undergo 
failure due to elongation. However, in order for clinicians to select the appropriate 
mesh for a patient, it is critical to first characterize the meshes’ biomechanical properties 
and biochemical content.  
In summary, we have characterized the collagen deposition and tensile 
properties of two different meshes used for pelvic floor repair as well as a chitosan-
coated polypropylene mesh for comparison.  We found that neo-tissue after 
implantation of Ch-PPM is stiffer than commercially available mesh used in a rat 
abdominal wall model. We also observed no significant difference in the ratio of 
collagen types I/III between mesh samples at 4 weeks or 12 weeks, and we did not find 
a relationship between the collagen type ratio and the mechanical strength of mesh 
samples after implantation. We believe that high stiffness observed with the Ch-PPM 
cold be due to the waviness or orientation collagen fibers and higher content of muscle 
tissue. We plan on building on this work and studying the orientation of the collagen 
fibers after implantation as well as quantifying the density of the cross-linking and 
collagen fiber concentrations biochemically.  
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Chapter 4 
 
Conclusion and Future Work 
4.1. Conclusion 
Over the last decade, surgical mesh has been widely used to reconstruct the 
pelvic floor, treating conditions like cystoceles (bladder prolapse) and uterine prolapse. 
Surgical mesh was introduced on the basis that it may provide a more durable repair 
than traditional procedures. Epidemiology studies have shown that while serious 
complications are uncommon, they are difficult to treat, have a high re-operation rate, 
and occasionally cause permanent disability, even after removal of the mesh. Long-term 
cure rates after implantation of mesh for pelvic floor disorders continue to be 
suboptimal and may be due to a mismatch of neo-tissue and native tissue strength, 
inadequate tissue ingrowth, or rejection of a foreign body. In order to develop a new 
generation of mesh and get a more complete picture of surgical mesh intended for 
pelvic floor repair, the mechanical properties, inflammatory response, and especially 
functional muscle growth must be evaluated. Ideally, this data allows surgeons to tailor 
their mesh selection based on patient needs.  
In addition to providing support to organs, meshes intended for pelvic floor 
reconstruction or abdominal hernia repair must achieve a high level of tissue 
incorporation while averting unwanted side-effects (127). One of the complications of 
using synthetic materials for muscle tissue reinforcement is excessive fibroplasia. 
Fibrous capsule formation inhibits the integration of the implanted material within the 
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tissue of interest and leads to a mismatch in mechanical properties with natural tissue, 
leading to a reduction of function and discomfort (75,128), which may require corrective 
surgeries due to complications including mesh erosion and mesh exposure among 
others.  Ideally, mesh intended for pelvic floor repair, when implanted, will allow for 
muscle tissue ingrowth and will match the mechanical integrity of native tissues 
without significant granulation tissue and or fibrosis.  Materials, which preferentially 
promote the attachment of myoblasts over fibroblasts, may elicit a less fibrotic host 
tissue response in vivo. 
 
In this thesis, the effects of chitosan coating on polypropylene mesh were 
evaluated for preferential attachment of muscle tissue as well as response after 
implantation in a rat abdominal wall model in comparison with commercially available 
mesh.  
The results of this thesis indicate that chitosan coatings may be highly suitable 
for use in pelvic floor repair and there are a considerable number of indicators to 
measure success in an animal model. This thesis worked towards bridging the fields of 
engineering and urogynecology by characterizing two commercially available meshes 
and introducing a chitosan-coated mesh for comparison. While the PPM and Col-PPM 
samples are commercially available surgical options, the differences in the contractile 
response and tissue integration are very different from one another. In comparison, we 
found that the Ch-PPM has a higher elastic modulus than both commercially available 
meshes. Compared to the Ch-PPM, we also see remarkable differences in macrophage 
phenotype, myogenin expression and tetanic force generation. We concluded that 
chitosan is a promising candidate coating for urogynecological materials due to its 
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ability to promote muscle tissue ingrowth and decrease the inflammatory response. 
More work is required to show how chitosan coated mesh performs in a large animal 
vaginal wall model (see Future Work). However, with marked differences between the 
properties of the three meshes in this thesis, this research should encourage engineers 
and clinicians to re-examine what properties likely lead to complications like mesh 
erosion, exposure, pain, etc., so that the appropriate mesh can be selected for patient 
use. 
The first half of Chapter 2 is centered around an in vitro study which showed that 
polypropylene meshes coated with 0.5% or 0.7% chitosan preferentially enhance the 
attachment of myoblasts when seeded 1:1 in co-culture with fibroblasts.  The 
microporous structures made of chitosan in the interstices of the polypropylene mesh 
also allowed for better cell attachment.  The polypropylene, served as the skeleton, 
while the lyophilized chitosan gel provided the cells with a microporous structure. Both 
0.5% and 0.7% Ch-PPM developed in this study may lead to an improved biomaterial 
for muscle repair applications.  By utilizing chitosan as a coating that increases the 
myoblast to fibroblast attachment, this study showed that the implanted mesh will 
reduce fibroplasia in vivo. While many studies have evaluated the effects of chitosan-
based biomaterials for dermal healing and cartilage and bone growth, this study was 
one of a handful to evaluate the effects of chitosan on myoblast and fibroblast cell 
attachment.  
The second half of Chapter 2 is focused on selecting the mesh that preferentially 
attached myoblasts over fibroblasts in vivo, and evaluating for functional muscle tissue 
when introduced to a rat abdominal wall model. We hypothesized that Ch-PPM will 
promote muscle tissue ingrowth and decrease inflammatory response in a rat 
  74 
abdominal wall model. The first metric we checked for was muscle ingrowth, which we 
tested two ways: functional muscle testing and myogenin expression. The second 
metric we examined was for severity of inflammatory response, which we tested two 
ways: through H&E staining and Immunolabeling of macrophage surface markers.  We 
found that Ch-PPM promotes tissue ingrowth. Functional muscle testing showed that 
0.5% Ch-PPM generates significantly higher tetanic force than PPM. Additionally, neo-
tissue surrounding Ch-PPM was characterized by myogenin expression between mesh 
fibers. Ch-PPM induced moderate inflammatory response. Histology showed a narrow 
band of fibrosis with a high number of macrophages. We immunolabeled the mesh 
samples for macrophages and found the presence of CD206+ M2--the presence of which 
is believed to lead to better remodeling outcomes with anti-inflammatory, regulatory 
and wound healing properties. This research showed that chitosan could be a viable 
option for skeletal muscle repair. Chapter 2 is the first study of its kind to use an early 
in vitro metric to evaluate muscle growth and see how if it led to functional muscle 
growth in vivo. Evaluating neo-tissue for muscle tissue ingrowth may decrease the 
mismatch in properties between native tissue and neo-tissue post-mesh implantation. 
Future research in this field may consider evaluating the myoblast to fibroblast ratio as 
an early indicator before beginning in vivo studies. Additionally, the ratio of myoblasts 
to fibroblasts in vitro may be a predictor for success in an in vivo environment.  
Chapter 3 continues on our work from Chapter 2 with the same abdominal wall 
model in a rat. We had a two-part aim for this study: (1) obtain information about the 
mechanical properties of Ch-PPM, and (2) establish the relationship between the ratio of 
collagen types I/III and mechanical properties after mesh samples are implanted in a 
rat abdominal wall model. We hypothesized that Ch-PPM neo-tissue will approach the 
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strength of native tissue better than commercially available mesh, and that the ratio of 
collagen types I/III can be used to predict the mechanical properties of neo-tissue in a 
rat abdominal wall model. To do this we did both ex vivo uniaxial tensile testing and 
collagen types I/III staining using picrosirius red. Results showed that using the ratio of 
collagen types I/III areas should not be used as a predictor for mechanical strength for 
all mesh types at both time points, however the score may be a better indicator. We also 
found that the ultimate tensile strength and elastic modulus were significantly higher 
for Ch-PPM at 12 weeks. This was the first study of its kind to characterize the 
mechanical properties and collagen deposition of a chitosan-coated mesh. It was also 
the first to evaluate the relationship between the collagen type I/III ratio and 
mechanical properties of neo-tissue after mesh implantation in an abdominal wall 
model. In this study, we contend that prior to determining the success of a mesh in 
clinical studies, one must have a comprehensive understanding of its mechanical 
behavior. A mismatch in properties between neo-tissue and native tissue may be a 
likely reason for failure of mesh or recurrent prolapse. By improving our understanding 
of the differences between meshes after host incorporation, we will have a foundation 
upon which to base differences in the behavior of meshes that may occur in clinical 
applications. 
Improved urogynecological meshes have the potential to improve our long-term 
success rates (100,129). The challenge in prolapse surgery is that while the prolapse 
itself may cause difficulties with bladder, bowel and sexual function, surgical correction 
may also affect these functions in unpredictable ways. By improving our understanding 
of the differences between meshes after implantation in a small animal model, we will 
have an enhanced understanding upon which to select the appropriate mesh for clinical 
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use. Recent progress in skeletal muscle wound management is mainly in terms of 
physiologic support of healing (71). Chitosan substantially contributed to research 
advances in the field of biomaterials. Improving the appearance and functionality of 
regenerated tissue in wounds may benefit from the versatility, functionality and 
efficacy of chitosan. 
 
4.2. Future Work 
This thesis raises many more questions than it answers. There are several exciting lines 
of research arising from this work that should be pursued and our lab is interested in 
pursuing research in three areas: 1) a mechanism study to understand the relationship 
between chitosan substrate and cell attachment; 2) an analogous large animal study to 
understand the effects of chitosan on smooth muscle of the vaginal wall; and 3) measure 
the anisotropic properties of the tissue using biaxial testing in a large animal model.  
First, there is no perfect animal model substitute for humans. Thus, the selection 
of an animal model is mainly driven by the research topic under investigation. 
However, with very little data available on the biomechanical behavior of animal 
models related to vaginal and pelvic floor function, the choice of a specific animal 
model can be difficult. Typically, after a small animal model, researchers progress to a 
larger animal model. In our case, it is necessary to continue our work in a larger animal 
model with functional anatomy similar to humans. Interestingly, the sheep has been 
evolving as a model for evaluating prolapse (3), and similar to women, uterovaginal 
prolapse occurs commonly in sheep. Sheep are an established reproductive model for 
humans, with long labors with large fetuses. Additionally, sheep spontaneously 
develop pelvic organ prolapse related to pregnancy and vaginal birth (130–132). 
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Abramowitch et al. conducted a review of animal models for PFD repair and his group 
discovered that pelvic anatomy and morphology in sheep are remarkably similar to 
humans and may be an appropriate alternative to the expensive and less accessible 
primate model (Fig. 4.1) (3). Additionally, added vascularity and presence of microflora 
in the vagina may have further impact on the host tissue response and biomechanical 
properties of materials used in vaginal repair relative to materials used for abdominal 
repair (133). A sheep model would also allow for a long-term study to be conducted 
and for vaginal placement as opposed to abdominal placement.  This proposed study 
would be the first of its kind to study chitosan coated meshes in an ovine model and 
would be a more thorough assessment of collagen and elastin content deposition after 
implantation in the vaginal wall. 
 
 
FIGURE 4.1. Histological trichrome images indicating the difference in morphology of the animal model 
from L to R (A) rat, (B) rabbit, (C) primate, (D) sheep, with respect to humans (E). The thickness of the 
epithelium varies among the animal models and with respect to human. However, it is evident that the 
vaginal wall of the sheep (D) holds a high degree of similarity to the human vaginal wall (E).(3) 
 
 
To move toward characterizing the anisotropic behavior of planar tissues such as 
the vagina, biaxial testing must be performed on ovine tissue samples in which stress or 
strain can be applied simultaneously and independently along two orthogonal axes 
(Fig. 4.2). A limitation in Chapter 3 is the method of uniaxial testing. Though it 
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permitted us to characterize and compare the mechanical properties of the coronal 
plane of the rat abdominal wall, to advance the state of the field, biaxial testing in the 
longitudinal and circumferential axes must be completed on ovine vaginal tissue after 
implantation of mesh samples.  Planar biaxial testing of vaginal tissue may provide a 
more complete characterization of the remodeling and effects of pregnancy, vaginal 
delivery, and birth injury (134). Constitutive models, described by Sacks et al., should be 
implemented into a finite element analysis to assess the behavior of the vagina under a 
variety of parameters (135,136). 
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FIGURE 4.2. Schematic of a biaxial testing device (131) 
 
 
Finally, further studies to elucidate the cellular and molecular mechanisms 
behind chitosan coatings and cell attachment. Cell surface receptors, such as integrins 
are crucial for adhesion of cells to a substrate as they recognize adsorbed ECM proteins 
leading to adhesion and reorganization of actin and cellular cytoskeleton. Future 
studies should be performed to elucidate the molecular role of substrate and cell 
adhesion molecules. Substrates have previously been observed to play an important 
role in protein adsorption and cell adhesion. In vitro work in our lab has shown that an 
organized actin and integrin!β3 network around the nuclei of myoblasts was observed 
with chitosan, whereas disrupted actin and integrin β1 network was observed under the 
same conditions for fibroblasts. Our lab concluded that chitosan promotes myoblast 
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adhesion by higher expression of integrin β3 and inhibits fibroblast adhesion due to 
disruption of actin and integrin β1 network. However, the interaction between chitosan, 
and adsorption of ECM proteins and integrin β3 and integrin β1 can be further 
analyzed to determine the molecular mechanisms behind the selective adhesion of 
myoblasts over fibroblasts. The effect of chitosan on polarization of macrophages and 
collagen deposition can also be analyzed to optimize skeletal muscle regeneration. 
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APPENDIX I: in vitro protocols 
 
How to Harvest Fibroblast Cells from CD-1 Mice 
1. Sacrifice 1 adult CD-1 mouse by CO2 inhalation. 
2. Spray 70% ethanol on skin to disinfect.  
3. Use #10 disposable scalpel and sterile scissors to remove hair and reveal skin. 
4. Skin biopsies are taken using a 3mm to 5mm diameter sterile biopsy punch. 
5. Using another sterile #10 disposable scalpel finely chop the biopsy into 1mm 
pieces. 
6. Put 2 mL Fibroblast Culture Media in sterile T25 flask (with filter top), remove 
medium from T25 flask (the bottom of the flask has to remain a bit wet). 
7. Carefully spread the skin fragments on the surface of the T25 flask. 
8. Transfer flask to the incubator and leave flask for a minimum of 3 days.  
 
 
9. After a minimum of 3 days, cells start growing around the skin biopsy; these 
cells are not yet fibroblasts, but then you know the skin piece is really attached to 
the bottom of the flask. When you see these cells you can carefully add some 
extra medium (1mL medium). If you do not see these cells yet, add only 0.5mL 
medium to prevent the skin pieces from starting to float. 
10. Look at flask every 2-3 days. You may add additional medium until 5mL 
medium in total.  Add only 0.5 ml medium every time very carefully. Finally, 
when you have added 5mL medium in total, you have to refresh the medium 
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every 2-3 days. Most likely, fibroblasts are then growing out of the initial cell 
layer. 
11. If necessary, because the fibroblasts start growing only from 3-4 sites in the T25 
flask, an internal trypsinization step can be performed to spread the fibroblasts 
over the whole T25 flask: 
a. Add 0.5mL 2x trypsin to T25 flask  
b. When the cells are detached, add 4.5mL medium  
12. When T25 flask is completely filled with fibroblasts, transfer fibroblasts to T75 
flask (0.5mL 2x trypsin + 9.5 ml medium). 
13. When the T75 flask is ~70% confluent, refer to the Passaging and Freezing of 
Fibroblast Cells protocol.  
 
For most experiments fibroblasts should be used between second and fifth passage.  Alternatively 
early passage cells can be frozen and used in future experiments.  
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How to Harvest Myoblast Cells from CD-1 Mice 
1. Sacrifice 1-5 neonatal mice by CO2 inhalation. 
2. Rinse the anterior tibialis of the left and right legs with 70% ethanol and remove 
with sterile scissors.  
3. Place all muscle samples in a 15mL tube with 5-8mL transport media.   
4. Place the 15mL tube in a foam icebox.  This can be left on ice for up to 2.5h. 
 
5. Aspirate the transport media and wash the sample with 10mL PBS 1X pH 7.2. 
6. Aspirate PBS and replace with 5mL PBS. 
7. Pour specimen into sterile Petri dish and mince using two sterile #10 scalpels. Repeat this 
till the muscle is slurry. 
8. Pipette up as much of the specimen as possible and transfer to a 15mL sterile tube. Wash 
the plate with an additional 5mL of PBS. 
9. Let the specimen settle to the bottom of the tube and aspirate off the PBS carefully. 
10. Pipette 10mL PBS onto the specimen. Cap tube and shake well. Let the specimen fall to 
the bottom of the tube, then aspirate off the PBS. 
11. Repeat steps 9+10 two more times. 
 
 
 
12. Aspirate the PBS, add 1.6mL of the Dispase II solution, 2mL of the Collagenase IV 
solution and 40µl of 0.25M CaCl2. 
13. Incubate in 37°C water bath for 1 hr.  
14. Tritrate (pipette up and down) 10 times, try to avoid producing foam, return to water bath 
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for an additional 15 mins.  
15. If tissue does not appear disassociated (by eye), repeat incubation and trituration.  
16. Place a 100µm nylon cell strainer on top of a 50mL tube, pre-wet filter with PBS.  
17. Pass sample through cell strainer and rinse strainer with an additional 5ml PBS.  
18. Pellet cells (1500 rpm for 5 min), aspirate supernatant and re-suspend in 10ml of Primary 
Culture Media. 
19. Preplate for 1.5 hrs on a standard Petri dish (non-TC coated!). This will allow 
contaminating fibroblasts to adhere, but myoblasts will not. 
20. Transfer medium to a T75 flask and discard the Petri dish. 
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How to Passage Cells from CD-1 Mice 
1. Before starting in sterile hood, visually check that the media is not cloudy (i.e. 
contaminated).  Cells should be at ~70% confluency.   
2. Aspirate the old culture media and wash with PBS 1X pH 7.2. 
3. Aspirate PBS, and add 5mL of 0.25% Trypsin with EDTA to detach monolayer 
for 5-7 minutes and place in the incubator. 
4. After 5 minutes, agitate (gently hit against side of table without having solution 
splash) and check under microscope. 
5. Tilt flask, Add 20mL of respective media to inactivate T/E. Make sure to pipette 
slowly across the base of the flask so that all cells, will slide to the bottom. 
6. Pipette the cell-media solution into a 50mL centrifuge tube and count cells using 
hemocytometer.  Centrifuge at 1000rpm for 7 minutes. 
7. Discard supernatant, and add 30 mL Primary Fibroblast Culture Media.   
8. Split into 3-4 T75 flasks.  Write down initials, date of creation, date of passaging, 
pass number, type of cell, and number of cells on flask. 
 
To freeze cells for future culture 
1. Aspirate media and wash with PBS. 
2. Aspirate PBS, and add 5mL of 0.25% Trypsin with EDTA to detach monolayer 
for 5-7 minutes and place in the incubator. 
3. Prepare freezer medium- 14mls 10% FBS, 2mls DMSO, 4mls neat FBS – total 
20mls = 20% FBS, 10% DMSO. Filter.  
4. -Add 1ml FM to pellet per cryo-tube. Usually split T75 into 2/3 cryo tubes. 1ml 
to each tube.  
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5. -Put in -80 freezer o/n then transfer to liquid N2.  
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Protocol: Seeding Myoblasts and Fibroblasts onto Ch-mesh (1:1) 
 
1. Sterilize aluminum washers using an autoclave. 
2. In the tissue culture hood, place sterile Ch-mesh samples (0.1-0.5 wt%) + the 
control (Avaulta Solo® Synthetic Support) in individual wells in a 6-well Cell 
Culture Plate, tissue culture treated, (BD Falcon™ 353046). 
3. Pipette 3 mL of laminin-1 solution (50 ug/mL; Sigma) in DPBS (without Ca/Mg; 
pH 7.4; Mediatech).  The mesh should be incubated overnight.  Meanwhile, label 
myoblast and fibroblast cells with DiI and DiO. 
 
4. In the tissue culture hood, remove mesh from laminin-1 solution, rinse with 
DPBS, and place into another sterile 6-well plate.    
5. Further sterilize the mesh under UV light in a clean bench under laminar flow. 
6. Soak the porous scaffolds with DMEM for 1 h. 
7. Place a sterilized stainless steel washer in each well so that the maximum surface 
of Ch-mesh is visible in the center. 
8. Trypsinize myoblasts and fibroblasts from their respective T75 flasks and count 
myoblast and fibroblast cells separately.   
9. Collect trypsinized solutions in two separate 50mL centrifuge tubes. 
10. Centrifuge both solutions (1500 rpm for 6 min). 
11. Aspirate old media and add growth media at a dilution so that both primary cell 
strains have a density of 5 x 105 cells/ml. 
12. Add 1.5 mL of the myoblast solution and 1.5 mL of the fibroblast solution to each 
well with the Ch-mesh and aluminum washers.  
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13. Place cells in incubator and replace media after 48 hrs. 
 
Protocol: Adhesion and Proliferation Assessment 
Assess cells on days 1,3 and 7. Then, aspirate culture medium and using sterile forceps 
remove the aluminum washers. Gently rinse with PBS and fix cells with 4% 
formaldehyde for 5 min.  Cells are ready to be counted under microscope.  Count 
myoblast and fibroblast cells separately. 
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Lab Recipes 
 
Fibroblasts 
Transport media and culture media (500 mL) 
100 mL  FBS (Gibco 26140-079) 
5 mL   Pen/Strep (Invitrogen 1514-122) 
5 mL   Hepes (Invitrogen 15630-106) 
5 mL   Sodium Pyruvate (Invitrogen 11360) 
385 mL  DMEM-F12 with Glutamax (Invitrogen 31331) 
Store in 4°C 
 
Freezing media 
1 mL  DMSO (Sigma D2650) 
9 mL  Transport media and culture media (Fibroblast) 
Make fresh, use immediately 
 
MRC-5 
Culture media (500 mL) 
50 mL  FBS (Gibco 26140-079) 
5 mL  Pen/Strep (Invitrogen 1514-122) 
445 mL DMEM low glucose (VWR 16777-126) 
Store in 4°C 
 
Maintenance media (500 mL) 
100 mL  FBS (Gibco 26140-079) 
5 mL  Pen/Strep (Invitrogen 1514-122) 
395 mL F-10 Nutrient Media (Gibco 11550-043) 
Store in 4°C 
 
 
 
 
How to use MRC-5 conditioned media for Primary Myoblast Culture: 
1. Thaw vial of MRC-5 cells, plate in T75 in 10 mL Culture Media. 
2. When ~70% confluent, split 1:4, when four flasks are ~70% confluent, split 1:4 again. 
(total 16 flasks) 
3. When 16 flasks are ~70% confluent, add 10 mL of Maintenance media to each flask 
and incubate overnight.   
4. Remove all of the media from all flasks and pool in an autoclaved 1L bottle.   
5. Pass through a 0.45µm (Nalgene 161-0045) filter unit and aliquot 5 mL per 15 mL 
centrifuge tube. Store at -20°C.   
6. Replace media on MRC-5 cultures with fresh maintenance media and repeat once 
more. 
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Myoblasts 
Transport media (100 mL) 
10 mL  FBS (Gibco 26140-079) 
2 mL  Pen/Strep (Invitrogen 1514-122) 
88 mL  F-10 Nutrient Media (Gibco 11550-043) 
Store in 4°C 
 
Collagenase 4 (Worthington Chemical 
LS004212) 
Re-suspend 100 mg in 25 mL sterile PBS, 
Freeze 2 mL aliquots (Store in -20°C) 
 
Dispase II (Roche 10 295 825 001) 
Freeze 2 mL aliquots (Store in -20°C) 
 
Trypsin, 0.25% (1X) with EDTA (Gibco 
25200-056) 
Dilute with PBS to make 0.1% stock.  
Freeze in 4 mL aliquots (Store in -20°C) 
 
bFGF stock (25 ng/µL) 
Add 1 mL sterile PBS to the 25 µg vial.  
Freeze 50 µL aliquots (Store in -20°C) 
 
Dexamethasone stock 
0.2M CaCl2 
 
Maintenance media (200 mL) 
40 mL   FBS (Gibco 26140-079) 
2 mL  Pen/Strep (Invitrogen 1514-122) 
158 mL F-10 Nutrient Media (Gibco 11550-043) 
Filter all ingredients through 0.22µm  
filter unit (Corning 430767) & store in 4°C 
 
Primary culture media (10 mL) 
5 mL Maintenance media with bFGF 
5 mL MRC-5 conditioned-media 
 
Just before use, add: 
1. 4 µL per 10 mL of bFGF 
2. 10 µl per 10 mL of dexamethasone 
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Protocol:(Chitosan(Mesh(Preparation(
 
Step 1: Take two sets of forceps, autoclave them and place them in two separate bags. 
 
Step 2: Use the precision balance to measure the desired amount of Chitosan (High 
Molecular Weight) and add it to the complementary amount of distilled H2O 
 
For 1% Chitosan-concentration, measure 1 g Ch, and add to 99 ml distilled H2O. For 0.5% 
Chitosan-concentration, measure 0.5 g Ch, and add to 99.5 mL distilled H2O. Etc. 
 
Step 3: Insert a clean magnetic stir bar and dissolve overnight on the stirring plate in 1% 
(v/v) acetic acid solution until a clear gel is obtained (about 24 hours). Keep the beaker 
covered with Parafilm. 
 
Keep consistent with the volume used in Step 2. To clarify, in the above examples, use 1 mL 
acetic acid with 99 mL distilled H2O.  
 
Step 4: In the sterile hood, sterilize this solution using Filter Units (Nalgene 568; 250mL 
Capacity, MF75TM Series). This solution can be stored for up to 30 days. Make sure to 
write your name, creation date, and expiration date in permanent marker on the bottle. 
Store this solution in the chemical cabinet. Place a magnetic stir bar in bleach. Remove 
all of the bleach with a KimWipe when you are ready for Step 7. 
 
Step 5: Cut Bard® polypropylene mesh into 1.2 x 1.2 cm squares. Weigh the sample.  
 
Step 6: Harrick Plasma Cleaner Instructions 
 
1. Turn on lower an upper power switches. 
2. Chamber is under vacuum. Bleed air into the chamber by opening 
needle valve 1/2 turn. When door can be opened, close needle valve.  
3. Put samples in open petri dish and place in chamber.  
4. Ensure “O” ring is clean and close door. 
5. Turn on the vacuum pump switch on the front of the Plasma Cleaner 
while holding the door shut for the first few seconds. 
6. Pump down to ~500 mtorr (green range of pressure where the plasma 
is the brightest pink color) 
7. Select RF level HI by gently turning the knob. This will start plasma 
generation. Coat sample with plasma for 32 seconds.  
8. Turn off RF. 
9. Turn off vacuum. 
10. Vent the chamber to atmosphere, open door, and close needle valve. 
11. Using rubber-tipped forceps, flip the sample over so the uncoated side 
is facing up on the petri dish. Repeat steps D-J. 
12. When finished, close door, and while holding door, start vacuum and 
allow pumping down to 300 mtorr. 
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13. Turn off vacuum and Plasma Cleaner power switches.  
 
 
Step 7: Immediately after removing the mesh from the Plasma Cleaner, insert the mesh 
and stir bar into a sterile bottle containing the filtered Chitosan solution from Step 4. 
Use rubber tipped forceps and make this transfer as quick as possible to ensure 
maximum charge retention. Close the cap tightly and place on top of the stirring plate. 
Leave this overnight. 
 
Step 8: Sterilize in UV (in the bio-hood) for 20 minutes, placed at an angle on a petri 
dish so both sides are exposed. Or: In the sterile hood and using the first pair of sterile forceps 
for handling the mesh, remove the mesh from the filtered chitosan solution. Sterilize this mesh by 
letting it soak in a petri dish in 70% ethanol for ten minutes and aspirating off the aqueous 
solution. Repeat 3 times. Let this dry in the sterile hood for an hour with the ventilation on. 
After an hour, if the mesh when handled is still not dry, then let it sit for another hour in the 
sterile hood till all ethanol has evaporated. 
 
Step 9: In the sterile hood and using the second set of sterile forceps, remove the mesh 
and put it into a 15 mL tube. Replace the cap, and place in the lyophilizer at -40°C for 24 
hours. Label the 15 mL tubes with your name, Chitosan concentration, and the creation 
date. 
 
Step 10: Lyophilizer Instructions 
 
1. Log onto NBTC Computer 
2. Loosen the caps of the 15 mL tubes containing the coated meshes. Do 
not make these too loose, however, or the vacuum in the lyophilizer will 
dislodge them. 
3. Place them in a glass container with no nicks on the glass and a solid 
lid. Make sure the black lid is tightly sealed. Carefully put the bent 
glass tube leading out of the lid into the machine. 
4. Place the glass container into a larger styrofoam container. Pour liquid 
nitrogen in the styrofoam box - this ensures the sample is kept frozen 
for the first two hours. 
5. Slowly turn the flat knob on the machine clockwise until you reach the 
highlighted part. This will open up the vacuum valve. If there is a 
problem with attaining a vacuum using the current setup, use parafilm 
to seal any leaks. 
6. Label glass container with Name, Date, Contents of Container, Net ID. 
Log on to NBTC computer. Leave samples for 24 hours. 
7. After 24 hours, retrieve samples and tighten all lids. Log off the NBTC 
computer. 
 
Step 11: Remove samples from lyophilizer. Weigh the sample in a pre-weighted 15 mL 
tube.  
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APPENDIX II: rat model protocols 
 
Location:!Weill!Surgical!Suite!
Protocol  Equipment or material 
required 
Prior to Euthanizing:  
1. Collect dry ice in Styrofoam box 
2. Bring camera for pictures 
3. Fill 15ml centrifuge tubes sent to histology with 
formalin using plastic pipette 
Styrofoam box 
Plastic pipette 
15ml centrifuge tubes 
10% formalin 
Euthanize  
1. Remove top of cage and replace with clear disc 
2. Attach tube and turn pink knob. Allow rat to 
remain in cage for 3 minutes after in stops 
breathing 
 
Necropsy  
1. Remove rat and place on blue drape 
2. Make midline incision and expose abdomen with 
both mesh samples. Using camera, take image. 
3. Excise mesh sample (one at a time) and label 
appropriate centrifuge tubes 
4. Place sample on corkboard and pin down sample. 
Using camera, take image. 
5. Use dogbone punch to collect tensile testing 
sample. Using camera, take image of process. 
Place sample in centrifuge tube and in dry ice 
Styrofoam box. 
6. Use remaining tissue for histology, place in 
formalin-filled centrifuge tubes.  
7. Wrap up animal in black trash bag and put in 
necropsy room. 
8. Wash down corkboard, forceps and scissors. 
Throw away other items. 
Clean forceps and scissors 
Blue drape 
Corkboard and pins 
Camera 
Black marker for labeling 
Dogbone punch 
 
!
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Location:!Weill!Surgical!Suite!
Protocol  Equipment or material 
required 
F-canister  
4. Fill in isoflurane so that it is in-between the line on the 
vaporizer. 
5. Check to make sure F-canister did not gain more than 
50 grams, replace if over 50 grams. 
6. Turn O2 knob clockwise (green knob). Set at 0.8L 
7. The top knob is for iso.  Push down and turn the knob. 
Set at 2. 
 
Rat Handling  
1. Turn on heated table. 
2. Tape blue drape down to heated table. 
3. On surgical table, inject meloxicam (dose will depend 
on size of rat - 1ml/250g rat) into scruff of rat. 
4. Hold the rat by the base of its tail and place in the 
induction box. Snap to close. Start iso at 3. 
Heating pads 
Sterile blue drapes (cut to 
size) 
Meloxicam bottle 
Needle Syringes 
 
 
Anaesthetize  
1. Turn on iso and O2. 
2. Once rat is sedated, place rat on blue drape, and put 
nose in nose cone. 
3. Use clippers to shave belly – keep swab flat with skin. 
Remove hair with handheld vacuum. 
4. Pinch toes hard – look for movement. 
5. Tape individual legs to prevent moving. Set iso at 2. 
6. Start swiping down the center of the skin patch with 
betadine and move to the outside.  Use 5 swab sheets. 
7. Take one swab, soak in betadine, and place on 
abdomen. Pinch toes hard to assess anesthesia depth. 
Set iso at 1.5-2 depending on the anesthesia depth. 
8. Administer small amount of eye lube to eyes of rat. 
9. Place sterile blue drape on top of rat with hole made 
for surgery. 
10. Keep monitoring the anesthesia depth by toe pinching 
every 5-10 minutes during anesthesia. Be careful not to 
touch the top side of the blue pad and keep your 
hands under the pad while trying to pinch the toe.  
11. Reduce iso to 1 when subcuticular sutures are being 
placed and gradually decrease to 0 when the suturing 
is complete. 
Wahl clippers 
Betadine surgical scrub 
Porous tape 
Portable Handheld 
vacuum 
SURGERY 
Adjustable chair (Gao 
room) 
4-0 prolene sutures 
4-0 vicryl sutures 
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Surgical scalpels #15 
Treatment cards 
Post-surgery  
1. Clean wound with hydrogen peroxide; use vetbond if 
necessary.  
2. Place tools in Bead sterilizer if required for more 
surgeries. 
3. If finished with surgery, weigh F-canister and label. 
4. For recovery, place the animal in an empty cage (no 
bedding) with an activated hand warmer placed 
underneath the cage. When the animal starts to 
ambulate, place it back in its home cage. 
Hydrogen peroxide 
Vetbond 
Bead sterilizer 
 
!
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Location: Bonassar’s Lab (Enduratec Station) 
 
Protocol  Equipment or material 
required 
Prepping the sample:  
8. Place sample in 15 ml centrifuge tube in -80 
freezer 
9. When ready to use, equilibrate sample in water 
bath for 10 min prior to testing sample  
15mL centrifuge tube 
Water bath 
Prepping the machine:  
3. Remove compression device using allen wrench 
4. Turn on load cell box (top machine) and 
equipment that controls movement of machine 
(bottom) 
5. Use 50 lb load cell (nub on top), then screw in the 
black knob at the bottom 
6. Screw clams into load cell (does not need to be 
tight) 
7. Only turn the black knob on the base NOT the 
load cell (it will kink) 
8. Adjust height between clamps with the allen 
wrench 
 
Running the software:  
9. Turn on both control boxes (switches on back) 
10. Open WinTest > Program Files 
11. Open My Computer > C:\ > Program Files > 
Enduratec > Natasha_1000g  
12. (Blue Line – disp of top actuator, Green line – 
force) 
13. Define waveform – delete everything and 
program system using Block Type 
a. Precondition with 10 sinusoidal cycles 
at 0.167 mm/sec -1 mm peaks (half sine, 
sine) 
b. Load-to-failure test performed at 0.15 
mm/sec (ramp) 
14. Timed data 
a. Scan time (total time) = 276 sec 
b. Scan Points = 552 
15. File Info > Browse > Natasha folder on 
desktop > NAME FILE 
16. Local > Select high (information flowing b/w 
computer and control box) 
17. Home (Position Axial -•-) > Set to -4.8 
18. Setup > Channels > Filters tab > 10 Hz load 
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and displacement  (frequency times 2) 
Begin testing:  
1. Using sandpaper capped around ends, 
insert sample into fixture (top clamp first). 
Push black knob up to move bottom clamp. 
To lock bottom clamp, use tool with blue 
handle. Take photo. 
2. To ensure that samples are tested 
consistently, an aspect ratio (length to 
width ratio) of 3 must be maintained for all 
samples 
3. Record all measurements in lab notebook 
(thickness, width, and length) 
4. Allow 5 min to equilibrate, squirt saline if 
necessary 
5. Setup > Channel: Load > Tare (check to 
see that Load equilibrates to 0 
6. Timed data > File Info > Select file (check 
to make sure you have highlighted the 
correct load) > Start 
7. Run button > Zero Start 
8. Take photo as load-to-failure is happening. 
Write in lab notebook where failure 
occurred 
Sandpaper 
Saline solution 
Calibrated calipers 
Camera 
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